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There are millions of organic compounds, some of them are heterocyclic 
containing atoms other than carbon in the ring system. These compounds are 
known to exhibit various biological activities such as antifungal, antibacterial, 
antitubercular, antipyretic, antitumor etc. Thus, these compounds show vital role 
in the field of pharmaceuticals because of their specific clinical reactivity.  
Thus, in the present work, heterocyclic compounds were selected. Among 
the various types of heterocyclic compounds, Acetyl pyrazolines and 
Dihydropyrimidines containing nitrogen in the ring, were studied.  
 The present work is divided into four chapters. 
Chapter-1 General Introduction 
Chapter-2 Synthesis and characterization 
 Section-I Synthesis of Chalcones of vanillin derivatives  
 Section-II Synthesis of Acetyl pyrazolines 
 Section-III Synthesis of Dihydropyrimidinthions  
 Section-IV Synthesis of Dihydropyrimidinons 
 Section-V      Synthesis of 2-Amino Dihydropyrimidines 
Chapter-3 Physico-chemical properties 
Section-I Acoustical Properties 
Section-II Density and Refractive index 
Section-III Conductance 
Section-IV Solubility and Thermodynamic parameters 
Section-V Partition Coefficient 
Section-VI     Dissociation Constants 
Section-VII Thermal Properties 
Chapter-4 Biological activities 
 
CHAPTER – 1: GENERAL INTRODUCTION 
 This chapter describes literature survey of synthesis, characterization, 
applications, physicochemical properties and antibacterial activities of 
heterocyclic compounds. 
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CHAPTER – 2: SYNTHESIS AND CHARACTERIZATION 
This chapter deals with synthesis and characterization of some 
Chalcones,  Acetyl pyrazolines, and Dihydropyrimidines derivatives. there are five 
sections in this chapter. 
Section-I Synthesis of Chalcone derivatives 
 
O
O
R
O
R=Aryl  
 
Section-II Synthesis of Acetyl pyrazolines 
 
O
O
N
R
N
O
R=Aryl  
 
 
 
Section-III Synthesis of Dihydropyrimidenthaions 
 
O
O
N
H
NH
NH
R
O
S
R=Aryl   
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Section-IV Synthesis of Dihydropyrimidenons 
 
O
O
N
H
NH
NH
R
O
O
R=Aryl  
 
Section-V Synthesis of 2-Amino-Dihydropyrimidines 
 
s
O
O
N
H
N
NH
R
O
NH2
R=Aryl  
 
 
 
CHAPTER – 3: PHYSICO-CHEMICAL PROPERTIES 
 Some physicochemical properties of Chalcones of vanillin derivatives have 
also been studied in dimethylformamide and Chloroform. The various physico 
chemical properties are discussed in the following seven sections: 
 
Section-1 Acoustical Properties 
Acoustical properties of solutions of different concentrations of Chalcones 
in dimethylformamide and Chloroform were studied by measuring density, 
viscosity and sound velocity (at 2 MHz) at 303.15 K. From these experimental 
data, various acoustical parameters such as isentropic compressibility, Rao’s 
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 molar sound function, relaxation strength, molar compressibility, Vander Waals 
constant, solvation number etc. were evaluated and the results are discussed in 
the light of solvent – solute and solute – solute interactions. 
 
Section-2 Density and Refractive index  
Refractive index and molar refraction are useful properties of a material. 
The molar refraction is of great importance for the calculation of dipole moment. 
In this section, the density and refractive index of Chalcones were measured in 
dimethylformamide and Chloroform solutions at 303.15 K.  
From the refractive index measurements, the density and refractive index 
of studied compounds were determined. The molar refraction of these 
compounds have also been evaluated from the density and refractive index 
values. 
 
Section-3 Conductance 
 This section deals with the conductance measurement of solutions of 
Chalcones in dimethylformamide and Chloroform solutions over a wide range of 
concentration at 303.15 K. From these experimental values, specific conductance 
and equivalent conductance were measured. 
 
Section-4 Solubility and Thermodynamic parameters 
In this section, solubility of Chalcones were determined at different 
temperatures (293.15-313.15 K) in Chloroform and Dichloromethane. Further, 
some thermodynamic parameters such as enthalpy, Gibb’s energy and entropy of 
different solutions have been evaluated from the experimental data. 
 
Section-5 Partition Coefficient 
  This section describes the partition coefficient of Chalcones in Water- 
Octanol system by UV spectrometer. From the spectral data, log P values were 
evaluated.  
 
Section-6 Dissociation Constants 
 This section deals with the dissociation constant of Chalcones in DMF- 
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water system at 303.15 K. 
 
Section-7    Thermal Properties 
 This section describes the thermal properties of Chalcones. Thermo 
Gravimetric Analysis (TGA) and Differential Thermal Analysis (DSC) 
measurements were made. From these thermograms, various kinetic 
parameters, thermal stability and malting points of various compounds were 
determined. 
 
 
CHAPTER – 4: BIOLOGICAL ACTIVITIES 
 The antibacterial activity of synthesized compounds was studied against 
some Gram positive and Gram negative bacteria in this chapter. 
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CHAPTER - I 
 
GENERAL 
INTRODUCTION 
 
 
INTRODUCTION 
The study of heterocycles is an evergreen field in organic chemistry. It 
always attracts the attention of scientists working not only in area of natural 
compounds but also in synthetic organic chemistry.   
Heterocyclic chemistry has been progressing owing to their natural 
occurrence, specific chemical reactivity and broad spectrum utility. Heterocyclic 
compounds are those which have a cyclic structure with two or more different 
kinds of atoms in the ring. 
The heterocyclic compounds are very widely distributed in nature and are 
essential to living organisms. They play a vital role in the metabolism of all the 
living cells. Among large number of heterocycles found in nature, nitrogen 
heterocycles are the most abundant specially those containing oxygen or sulphur 
due to their wide distribution in nucleic acid illustration and their involvement in 
almost every physiological process of plants and animals. 
 The determination of structure of a biologically active molecule provides a 
two fold benefit to pharmacy and medicine. It makes possible to pursue research, 
leading to synthesis and modification of the structure. Various application of 
heterocyclic compounds has been reported1-9. Some of these compounds are 
also known to be used as a starting material for the synthesis of new drugs10-21.  
Most of the alkaloids, pigments (such as indigo, haemoglobin, anthocyanin 
etc.) and some well known drugs (like penicillin, streptomycin, sulphathiazole, 
pyrenthrin, rotenmone, strychnine, reserpine, etc.) consist of heterocyclic ring 
system.  
Taking in view of the applicability of bio-active heterocyclic compounds, 
the present work was undertaken to synthesize some new heterocycles bearing 
pyrimidines and pyrazolines nucleus. 
 
 
. 
 
 
 
 
 
AIMS AND OBJECTIVES: 
 To synthesize several derivatives like chalcones, Acetyl pyrazoline, 
dihydropyrimidine-2H-thiones,dihydropyrimidine-2H-imines,  dihydropyrimi- 
dine-2H-ones  bearing pyrimidines and pyrazoline nucleus. 
 To characterize these synthesized compounds for structure elucidation by 
IR, 1H NMR and Mass spectral studies. 
 To study the physico chemical properties such as acoustical properties, 
density, refractive index, conductance, heat of solutions, thermal properties, 
dissociation constants and partition co-efficient of some synthesized 
compounds in different solvents. 
 To evaluate antibacterial activity of some synthesized compounds against 
different bacterial strains in DMSO. 
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    INTRODUCTION 
The chemistry of chalcones has generated intensive scientific studies 
throughout the world, due to their biological and industrial applications. 
Chalcones are characterized by their possession of a structure in which two 
aromatic rings are linked by an aliphatic three carbon chain. 
Chalcones are prepared by condensation of aryl ketones with aromatic 
aldehydes in presence of suitable condensing agents. They undergo a variety 
of chemical reactions and are found to be useful in the synthesis of variety of 
heterocyclic compounds. Chalcones have also been used as intermediate for 
the preparations of compounds having therapeutic value1.  
This class of compounds also serve as precursors for the synthesis of 
different classes of various flavonoids, which are common substances in 
plants that have an array of biological activities.2,3 Most of the phenolic natural 
products are potentially useful intermediates for many industrial products and 
agrochemical applications, including food sciences. The phenolic natural 
products are closely related to free radicals, which play a major role in the 
progression of many pathological disturbances.4 
Literature survey reveals that chalcones derivatives exhibit diverse 
pharmacological activities such as potential antimicrobial agents5, cytotoxic 
agents6, Antimitotic7, antiinflammatory8,9, antiviral10 ,Fungicidal11 anesthetics, 
etc. Dimmock et al. have reported quantitative structure-activity relationship 
study of some chalcones.12 Rozmer et al. have also reported different effects 
of two cyclic chalcone analogues on cell cycle of Jurkat T cells13. Wang et al. 
have reported anticancer activity of 2-alkylaminomethyl-5-
diarylmethylenecyclopentanone hydrochlorides.14 Kirk et al. have reported 
antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium 
falciparum-infected erythrocytes.15 The anti-proliferative activities of some 
chalcones have also been studied by Wu et al.16 Some other biological 
activities of Chalcone derivatives have also been reported.17  
Different methods are available in the literature for the synthesis of 
chalcones.18-21 The most convenient method is the one, that involves the 
Claisen- Schimidt condensation of equi molar quantities of an aryl methyl 
ketones with aryl aldehyde in presence of alcoholic alkali22. 
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                                                                      Section-I: Synthesis of Chalcones 
 
6
Various workers have synthesized different types of Chalcones.23-26 
Recently, interest has focused on the ferrocenyl chalcones which have been 
reported by Noh et al.27 Zhou et al.  have reported cyclodimerization of α, β-
unsaturated ketone by samarium iodide.28  Some new 1,5-benzodiazepines 
have also been synthesized by Escobar et al. by microwave irradiation.29 
The chalcones have been found to be useful for the synthesis of variety 
of heterocyclic compounds such as cyanopyridone30, pyrrolobenzodiazepine 
31, oxirane32, 1-carboxamidepyrazolines33, benzodioxane34 oxopyrimidines35, 
benzodiazepine36, oxazapine 37 etc. 
Thus, due to importance of this class of compounds, in the present 
section, some new chalcones of vanillin derivatives have been synthesized. 
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    EXPERIMENTAL 
 
Synthesis of (2E)-1-(4-ethoxy-3-methoxyphenyl)-3-phenylprop-2-en-1-
one: (NVA-01).  
 
 
 [A] Synthesis of 3,-methoxy4-ethoxy benzaldehyde:  
 An aqueous solution of vanillin (0.01M) was refluxed at 95-97 0C for 
half an hour with stirring. To this solution, few drops of NaOH and diethyl 
sulphate (0.012 M) were added slowly and again the reaction mixture was 
refluxed for 5 to 7 hrs with stirring. After the completion of reaction, organic 
layer was isolated and cooled at room temperature. The solid crude product 
was isolated and crystallized from absolute ethanol. (Scheme-1) 
 
 [B] Synthesis of (2E)-1-(4-ethoxy-3-methoxyphenyl)-3-phenylprop-
 2-en-1-one: 
 A mixture of 3,-methoxy4-ethoxy benzaldehyde (0.01 M) and 
substituted acetophenone (0.012 M) in 40 ml MeOH was stirred for 24 hours 
in presence of few drops of aqueous solution of NaOH. The product was 
filtered and dried. The recrystalisation was done in ethanol. (Scheme-2) 
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Table 1.1: Physical constants of chalcones. 
Sr. No. Code R M.F. M. Wt. (g/mol) 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 NVA -1 -4-Cl- C18H17ClO3 316 0.51 153 73 
2 NVA -2 4-NO2- C18H17 NO5 327 0.58 153 59 
3 NVA -3 -H C18H18O3 282 0.49 132 66 
4 NVA -4 4-CH3 - C19H20O4 296 0.43 124 67 
5 NVA -5 4-OCH3- C18H20O4 312 0.68 151 73 
6 NVA -6 4-Br- C18H17BrO3 361 0.63 134 57 
7 NVA -7 4-OH- C18H18O4 298 0.30 133 59 
8 NVA -8 2,4-OCH3- C20H22O5 343 0.59 129 64 
9 NVA -9 3-Cl- C18H17ClO3 316 0.57 170 75 
 
 
* MeOH:Chloroform: 2:8 
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The characterization was done by IR, 1H NMR and mass spectra. 
 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
Spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. Figure 1.1 shows IR spectra of NVA-1. The IR spectral data for NVA-
1 is given in Table 1.2. The spectral data for all other compounds are reported 
in Table 1.3. 
 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 1.2 shows 
NMR spectra of NVA-1. The spectral data for NVA-1 is given in Table 1.4.  
 
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. Figure 
1.3 shows mass spectra of NVA-1.The proposed mass fragmentation of the 
same compound is also given in Scheme 1.1. 
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Figure 1.1: IR spectra of (2E)-1-(4-ethoxy-3-methoxyphenyl)-3-
 phenylprop-2-en-1-one: (NVA-01). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.2: IR spectral data (2E)-1-(4-ethoxy-3-methoxyphenyl)-3-
   phenylprop-2-en-1-one: (NVA-01). 
 
 
Type Vibration mode 
Frequency in cm-1 
Observed Reported 
Alkane 
C-H str. (asym.) 2933.76 2975-2920 
C-H str. (sym.) 2833.24 2880-2860 
C-H def. (asym.) 1450.4 1470-1435 
C-H def. (sym.) 1406.36 1395-1370 
Aromatic 
C-H str. 3006.71 3100-3000 
C=C str. 1508.81 1585-1480 
C-H i.p. def. 1074.3 1125-1090 
C-H o.o.p. def. 824.4 860-810 
Ketones C=O str. 1675 1685-1645 C=O str. (alip.) 1508.8 1585-1480 
Ether C-O-C str. (asym.) 1255 1400-1000 C-O-C str. (sym.) 1074 1075-1020 
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Table 1.3: IR spectral data of synthesized chalcones. 
Compounds C=C C=O C-O-C C-H (asym.) R 
NVA-1 1512.32 1653.73 1232.54 2958 844 
NVA-2 1495.52 1678.12 1248.34 2953 1318 
NVA-3 1488.64 1682.32 1257.64 2955 -- 
NVA-4 1522.31 1642.47 1269.05 2922 2953 
NVA-5 1512.32 1665.14 1273.05 2977 1276 
NVA-6 1524.85 1654.84 1248.21 2967 778 
NVA-7 1502.32 1662.14 1270.05 2973 3412 
NVA-8 1518.12 1677.65 1272.42 2912 1231 
NVA-9 1498.64 1679.12 1243.65 2970 776 
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Figure 1.2: 1H NMR spectra of (2E)-1-(4-ethoxy-3-methoxyphenyl)-3-phenylprop-2-en-1-one: (NVA-01). 
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Table 1.4: 1H NMR spectral data of (2E)-1-(4-ethoxy-3-  
 methoxyphenyl)-3-phenylprop-2-en-1-one: (NVA-01). 
 
   
O
O
O
CH3
CH3
Cl
a
b
c
d
e
fg
h
i
j
j'
i'
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons Multiplicity Inference 
1 3.34 3 singlet -OCH3 
2 4.01-4.08 2 quartet -OCH2 
3 1.30-135 3 triplet -CH3 
4 6.96-6.99 1 doublet Ar-Hd 
5 7.34-7.37 1 doublet Ar-H’e 
6 7.53 1 singlet Ar-H’f 
7 8.14-8.17 2 singlet -CH-CHg,h 
8 7.60-7.63 2 doublet Ar-Hl+l” 
9 7.72-7.83 2 doublet Ar-Hj+j’’ 
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Figure 1.3: Mass spectra of (2E)-1-(4-ethoxy-3-methoxyphenyl)-3-phenylprop-2-en-1-one: (NVA-01). 
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Scheme1.1:Proposed mass fragmentation (2E)-1-(4-ethoxy-3-
methoxyphenyl)-3-phenylprop-2-en-1-one: (NVA-01). 
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  INTRODUCTION 
Pyrazolines are well known important nitrogen-containing 5-membered 
heterocyclic compounds having a wide spectrum of biological activities which 
stimulated the research activity in this field. 
Most of the pyrazoline derivatives are known to exhibit antimicrobial,2 
anticonvulsant 3, anti-inflammatory4, antibacterial5 and anti-tumor6 properties. 
Lévai et al. have reported synthesis of some hydroxylated 3,5-diaryl-2-
pyrazolines and studied their structure activity relationships.7 The 
antidepressant activities of some 3,5-diphenyl-2-pyrazolines have also been 
reported by Palaska et al8. Solankee et al studied the antibacterial activity by 
using agar diffusion method9 of some acetyl pyrazolines. Recently, 
Gowramma et al. have reported for anticancer activity of some pyrazolines.11 
Various methods have been reported for the preparation of acetyl-
pyrazoline derivatives1 ,12-15. Havrylyuk et al. have reported synthesis of novel 
thiazolone based compound containing pyrazole moiety 16. Acetyl-pyrazolines 
can also be constructed by the cyclo condensation of chalcones with 
hydrazine hydrate17. A novel region selective synthesis of aryl-substituted 
pyrazolines and pyrazoles has been developed by Alex et al.18. 1-Acetyl-3-(4-
chlorophenyl)-5-(4-methylphenyl)-2-pyrazoline has been synthesized and 
characterized by elemental analysis, IR and X-ray single crystal diffraction by 
Guo et al. 10  
Spectrophotometric determination of pyrazolines and some acrylic 
amides and esters have been reported by Mattocks et al.19 Le´vai et al. have 
reported  the synthesis of  α,β-unsaturated ketones with hydrazines affords 
3,5-disubstituted 2-pyrazolines.20 Kim et al. have reported the synthesis of  
cyanopyrazoline derivatives21 whereas Koval et al. have reported synthesis 
and structures of new copper complexes with the pyrazole-containing 
ligands.22 Selvi et al. synthesized some of these derivatives by using 
microwave.23 Jian et al. have also reported synthesis, characterization, crystal 
structure studies of some pyrazoline derivatives.24 
In the present section, some new acetyl pyrazolines have been 
synthesized. 
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EXPERIMENTAL 
Synthesis of 1-[3-(4-ethoxy-3-methoxyphenyl)-5-phenyl-1H-pyrazol-1-
yl]ethanone: 
 
[A] Synthesis of 3,-methoxy4-ethoxy benzaldehyde: 
An aqueous solution of vanillin (0.01M) was refluxed at 95-97 0C for 
half an hour with stirring. To this solution, few drops of NaOH and diethyl 
sulphate (0.012 M) were added slowly and again the reaction mixture was 
refluxed for 5 to 7 hrs with stirring. The reaction was monitored by TLC. After 
the completion of reaction, organic layer was isolated and cooled at room 
temperature. The solid crude product was isolated and crystallized from 
absolute ethanol. (Scheme-1) 
[B] Synthesis of (2E)-1-(4-ethoxy-3-methoxyphenyl)-3-phenyl prop-
 2-en-1-one: 
A mixture of 3,-methoxy4-ethoxy benzaldehyde (0.01 M) and 
substituted acetophenone (0.012 M) in 40 ml MeOH was stirred for 24 hours 
in presence of few drops of aqueous solution of NaOH. Then, the product was 
filtered and dried. The recrystalization was done in ethanol. (Scheme-2) 
 
[C] Synthesis of 1-[3-(4-ethoxy-3-methoxyphenyl)-5-phenyl-1H-
 pyrazol -1-yl]ethanone: 
 
A solution of Hydrazine hydrate (0.012 M), substituted (2E)-1-(4-
ethoxy-3-methoxyphenyl)-3-phenylprop-2-en-1-one (0.01M) in glacial acetic 
acid was refluxed for 12 hours. The reaction mass was then poured in water 
and filtered it. All the synthesized compounds were recrystallized from 
hexane. (Scheme-3) 
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Table 1.1: Physical constants of Dihydropyrimidinones. 
 
Sr. No. Code R M.F. 
M. Wt. 
(g/mol) 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 NVB -1 4-CH3- C21H22 N2 O3 350 0.50 197 65 
2 NVB -2 4-Cl- C20H19 N2 O3 370 0.51 223 59 
3 NVB -3 4-OH- C20H20 N2 O4 352 0.45 254 61 
4 NVB -4 4-OCH3- C21H22 N2 O4 366 0.49 221 58 
5 NVB -5 2,4- OCH3- C20H20 N2 O5 368 0.54 224 59 
6 NVB -6 4-Br- C20H19 BrO3 415 0.61 240 54 
7 NVB -7 4-NO2- C20H19 N3O5 381 0.34 213 49 
8 NVB -8 -H C20H20 N2 O3 336 0.55 270 61 
9 NVB -9 3-Cl- C20H19 N2 O3 370 0.43 231 57 
* Ethyl acetate:Hexane: 2:8 
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The characterization was done by IR, 1H NMR and mass spectra. 
 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
Spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. Figure 1.1 shows IR spectra of NVB-1. The IR spectral data for NVB-
1 is given in Table 1.2. The spectral data for all other compounds are reported 
in Table 1.3. 
 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 1.2 shows 
NMR spectra of NVB-1. The spectral data for NVB-1 is given in Table 1.4.  
 
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. 
Figure 1.3 shows mass spectra of NVB-1. The proposed mass fragmentation 
of the same compound is also given in Scheme 1.1. 
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 Figure 1.1: IR spectra of 1-[3-(4-ethoxy-3-methoxyphenyl)-5-
 phenyl-1H-pyrazol-1-yl]ethanone: (NVB-01). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 1.2: IR spectral data of 1-[3-(4-ethoxy-3-methoxyphenyl)-5-
 phenyl-1H-pyrazol-1-yl]ethanone:(NVB-01). 
 
Type Vibration mode Frequency in cm
-1 
Observed Reported 
Alkane 
C-H str. (asym.) 2956 2975-2920 
C-H str. (sym.) 2865 2880-2860 
C-H def. (asym.) 1429 1470-1435 
C-H def. (sym.) 1387 1395-1370 
Aromatic 
C-H str. 3103 3100-3000 
C=Cstr. 1581 1585-1480 
C-H i.p. def. 1122 1125-1090 
C-H o.o.p. def. 844 860-810 
Ketones C=O str. (alip.) 1678 1740-1680 
Nitrogen 
C-N str. 1253 1350-1200 
N-H str. 3145 3400-3200 
N-H def. 1581 1650-1500 
Ether C-O-C str. (asym.) 1182 1400-1000 C-O-C str. (sym.) 1072 1075-1020 
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Table 1.3: IR spectral data of synthesized Dihydropyrimidinones. 
 
 
Compounds 
 
C=O 
(cyclic) 
C=O 
(alip.)
N-H C=C 
 
C-H 
(asym.) R 
NVB-1 1678 1690 3145 1581 2958 3103 
NVB-2 1721 1664 3343 1537 2953 698 
NVB-3 1734 1672 3245 1531 2955 3324 
NVB-4 1723 1665 3309 1521 2922 2853 
NVB-5 1711 1667 3261 1519 2967 2976 
NVB-6 1707 1678 3286 1534 2973 567 
NVB-7 1720 1659 3311 1520 2912 1322 
NVB-8 1734 1672 3245 1519 2970 776 
NVB-9 1735 1677 3285 1501 2962 671 
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Figure 1.2:1H NMR spectra of 1-[3-(4-ethoxy-3-methoxyphenyl)-5-phenyl-1H-pyrazol-1-yl] ethanone: (NVB-01). 
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 Table 1.4: 1H NMR spectral data of 1-[3-(4-ethoxy-3-
 methoxyphenyl)-5-phenyl-1H-pyrazol-1-yl]ethanone:(NVB-01). 
   
N
O
O CH3
CH3
N
O a
bcd
e
f
g
h
i
i'
j
j'
k
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons Multiplicity Inference 
1 1.31 3 triplet -CH3 
2 4.02 2 quartet -OCH2 
3 7.30-7.35 2 d-d Ar-Hc-Hd 
4 7.37 1 singlet Ar-H’e 
5 3.80 3 singlet -OCH3 
6 6.97 1 singlet -CH 
7 2.49 3 singlet -CO-CH3
8 7.78-7.83 2 doublet Ar-Hl+l” 
9 7.64-7.69 2 doublet Ar-Hj+j’’ 
10 2.39 3 singlet Ar-CH3
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Figure 1.3:Mass spectra of 1-[3-(4-ethoxy-3-methoxyphenyl)-5-phenyl-1H-pyrazol-1-yl]ethanone: (NVB-01). 
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 Scheme 1.1: Proposed mass fragmentation of 1-[3-(4-ethoxy-3-
 methoxyphenyl)-5-phenyl-1H-pyrazol-1-yl]ethanone: (NVB-01). 
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  INTRODUCTION 
 Dihydropyrimidines consists of a six membered heterocyclic ring 
having two nitrogen atoms at one and three positions. In 1893, Pietro Biginelli 
discovered a multicomponent reaction which leads to partly reduced 
pyrimidinone derivatives1 Since that time, the Biginelli reaction has been 
known as an efficient one-pot reaction protocol to prepare 3,4-
dihydropyrimidine-2(1H)- thion (DHPM) derivatives 2 
These heterocyclic compounds exist in a variety of natural and 
synthetic organic compounds and are known to possess wide spectrum of 
biological and therapeutic properties such as antibacterial, anti viral, anti 
tumor and anti inflammatory activities 3-5. Recently, some of dihydropyrimidine 
2(1H)-thiones analogs have emerged as integral backbones of several 
calcium channel blockers, antihypertensive agents and α-la-adrenergic 
receptor antagonists 6-10. Moreover, several alkaloids, isolated from marine 
sources also contain dihydropyrimidine core unit. These alkaloids also exhibit 
interesting biological properties. 11-12 Various derivatives of dihydropyrimidines 
have been synthesized (13-15), one of which is dihydropyrimidithiones.  
Many researchers have attempted to determine the synthetic routes 
and various biological activities of these compounds (16-18). The 
antihypertensive agent of pure 4-aryl-3,4-dihydro-pyrimidin-2(1H)-ones and 
thiones via enzymatic resolution have been reported by Kappe et al.19  
Furthermore, Desai et al. 20 and Kumar et al. 21 have reported the anti 
tubercular activity of some 1,4- dihydropyrimidines2(H)- thiones. Hattori et al. 
designed some dihydropyrimidines-2(H)- thiones and studied their anticancer 
activities.22 The use of these derivatives have also been used in oral adjuvant 
chemotherapy. 23 Kumar et al. have also studied in vitro cytotoxicity against 
Vero cell for some novel Biginelli Dihydropyrimidines. 24 
 These developments led to the preparation and pharmacological 
evaluation of 3,4-dihydropyrimidines2(H)-thiones (DHPMs) of biological 
interest. Sabitha et al.25 have synthesized dihydropyrimidinones by three 
component condensation of an aldehyde, a keto ester and thiourea in the 
presence of a catalytic amount of VCl3 in solution phase. Atwal et ai have also 
reported synthesis of substituted 1,2,3,4-Tetrahydro-6-methyl-2-thioxo-5-
pyrimidinecarboxylic acid esters.26 
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In recent years, several methods for the synthesis of DHPMs have 
been developed to improve and modify the Biginelli reaction by means of 
microwave irradiation 27, ultrasound irradiation28, ionic liquids29, Lewis and 
protic acid promoters such as lanthanide triflate30, H3BO331, silica chloride32, 
HCOOH33 etc. Kappe et al. have reported direct microwave-assisted Pd(0)-
catalyzed/Cu(I)-mediated carbon-carbon cross-coupling of 3,4-
dihydropyrimidine-2-thiones.34  Wang et al. have also reported one-pot 
Biginelli condensation reaction for the synthesis of some noval 
dihydropyrimidithiones.35 However, in spite of their potential utility, many of 
these reported one-pot protocols suffer from drawbacks such as the use of 
expensive reagents, strong acidic conditions and long reaction times.   
 Further, Dihydropyrimidine2(H)-thiones, a variety of different 
combinatorial protocols based on the classical Biginelli MCR have been 
advanced36.  Salehi et al. have reported synthesis of dihydrothiopyrimidine-
2(H)- thiones by using over silica sulfuric acid as a reusable catalyst under 
solvent-free conditions37. Manjula et al. have reported that the cupric chloride–
lithium chloride combination catalyst as an efficient reagent system for the 
single pot Biginelli reaction38.  Photocatalytic oxidation of dihydropyrimidinone-
2(H)- thiones using titanium dioxide suspension has also been studied by 
Nasr-Esfahani et al.39  
In the present section, some new dihydropyrimidine2(H)-thiones have 
been synthesized. 
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EXPERIMENTAL 
Synthesis of 4-(3,-methoxy4-ethoxyphenyl)-6-methyl-2-Thio-N-phenyl-
1,2,3,4-tetrahydropyrimidine-5-carboxamide. 
 
[A] Synthesis of 3,-methoxy4-ethoxy benzaldehyde: 
An aqueous solution of vanillin (0.01M) was refluxed at 95-97 0C for 
half an hour with stirring. To this solution, few drops of NaOH and diethyl 
sulphate (0.012 M) were added slowly and again the reaction mixture was 
refluxed for 5 to 7 hrs with stirring. The reaction was monitored by TLC. After 
the completion of reaction, organic layer was isolated and cooled at room 
temperature. The solid crude product was isolated and crystallized from 
absolute ethanol. (Scheme-1) 
 
[B] Synthesis of 3-oxo-N-phenylbutanamide: 
A mixture of substituted aniline (0.01 M) and ethyl acetoacetate (0.012 
M) in 40 ml toluene was refluxed for 12 hours in presence of few drops of 
slurry of NaOH in water. The reaction was monitoring with TLC. The excess of 
toluene was distilled out and the reaction mixture was taken in hexane and 
stirred with glass rod. The products were isolated in hexane and filtered. The 
crude product was dried. This product was taken in aqueous NaOH solution 
and neutralized with dilute HCl. The recrystalisation was done in ethanol. 
(Scheme-2) 
 
[C] Synthesis of 4-(4-ethoxy3-methoxyphenyl)-6-methyl-2-Thio-N-
       phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamide: 
A solution of 3-methoxy4-ethoxy aldehyde (0.01 M), substituted 
diketones (0.012 M) and Thiourea (0.015 M) in methanol was refluxed for 12 
hours in presence of few drops of con. HCl as catalyst. The product was 
isolated and crystallized from ethanol. All the synthesized compounds were 
recrystallized from ethanol. (Scheme-3) 
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Table 1.1: Physical constants of Dihydropyrimidinones. 
Sr. No. Code R M.F. M. Wt. (g/mol) 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 NVT-1 4-Cl C21H22 ClN3O3 S 431 0.64 188 61 
2 NVT -2 3,4-Cl- C21H21 Cl2N3O3 S 466 0.54 172 53 
3 NVT -3 4-OCH3 C22H25 N3 O3 S 427 0.68 210 59 
4 NVT -4 3-Cl,4-F- C21H21 ClFN3O3 S 449 0.46 203 57 
5 NVT -5 3,4- CH3 C23H27 N3O3 S 425 0.68 219 57 
6 NVT -6 3-Cl- C21H22 ClN3O3S 431 0.77 238 62 
7 NVT -7 4-F- C21H22 ClN3O3 S 415 0.82 186 54 
8 NVT -8 2-Cl,5-F- C21H21 ClFN3O3 S 449 0.59 232 62 
9 NVT -9 C6H5- C21H23N3O3 S 397 0.63 154 58 
10 NVT-10 2,4-Cl- C21H21 Cl2N3O3 S 466 0.70 184 67 
* Ethyl acetate:Hexane: 2:8 
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The characterization was done by IR, 1H NMR and mass spectra. 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
Spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. Figure 1.1 shows IR spectra of NVT-1. The IR spectral data for NVT-
1 is given in Table 1.2. The spectral data for all other compounds are reported 
in Table 1.3. 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 1.2 shows 
NMR spectra of NVT-1. The spectral data for NVT-1 is given in Table 1.4.  
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. Figure 1.3 
shows mass spectra of NVT-1The proposed mass fragmentation of the same 
compound is also given in Scheme 1.1. 
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Figure 1.1: IR spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl- 2-
Thio -N-phenyl- 1,2,3,4-tetrahydropyrimidine-5-carboxamide: (NVT-01).                      
  
 
Table 1.2: IR spectral data of 4-(3,methoxy4-ethoxyphenyl)-6-methyl  -2-
Thio-N-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamide:(NVT-01). 
Type Vibration mode Frequency in cm-1 Observed Reported 
Alkane 
C-H str. (asym.) 2943 2975-2900 
C-H str. (sym.) 2871 2880-2810 
C-H def. (asym.) 1455 1480-1435 
C-H def. (sym.) 1361 1985-1350 
Aromatic 
C-H str. 3105 3100-3000 
C=C 1510 1585-1480 
C-H i.p. def. 1115 1125-1090 
C-H o.o.p. def. 829 860-810 
Ketones C=O str.(cyclic) 1735 1740-1680 C=O str. (aliphatic) 1656 1710-1650 
Nitrogen 
C-N str. 1259 1350-1200 
N-H str. 3310 3400-3200 
N-H def. 1656 1650-1500 
Ether C-O-C str. (asym.) 1178 1400-1000 C-O-C str. (sym.) 1026 1075-1020 
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Table 1.3: IR spectral data of synthesized Dihydropyrimidinones. 
 
Compounds 
IR ૅ, (cm-1) 
C=O 
(cyclic) 
C=O 
(alip.) N-H 
C=C 
 
C=H 
(asym.) R 
NVT-1 1735 1656 3310 1510 2943 731 
NVT-2 1739 1646 3317 1519 2944 765 
NVT-3 1716 1679 3281 1529 2949 1132 
NVT-4 1719 1684 3269 1528 2942 793 
NVT-6 1722 1674 3274 1527 2941 812 
NVT-7 1719 1663 3321 1527 2953 689 
NVT-8 1727 1677 3267 1539 2952 749 
NVT-9 1720 1658 3319 1510 2932 762 
NVT-10 1722 1667 3267 1514 2967 758 
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Figure 1.2: 1H NMR spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl-2-Thio-N-phenyl-1,2,3,4- tetrahydropyrimidine  -
5-carboxamide:(NVT-01).  
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Table 1.4: 1H NMR spectral data of 4-(3,methoxy4-ethoxyphenyl) -6-
 methyl-2-Thio-N-phenyl-1,2,3,4-tetrahydropyrimidine-5-
 carboxamide: (NVT-01). 
 
   
NH
N
H
NH
O
CH3
O
O
CH3
S
CH3
Cl
a
b
c
d e
f
g
h
ij
k
l
l'
m
m'
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons Multiplicity Inference 
1a 1.15-1.29 3 Triplet -CH3 
2b 3.81 2 quartets -OCH2 
3c 6.88-6.90 1 doublet Ar-Hc 
4d 6.80-6.83 1 doublet Ar-Hd 
5e 7.01 1 singlet Ar-H’e 
6f 3.56-3.66 3 singlet -OCH3 
7g 5.35 1 singlet Ar-Hg 
8h 9.81-9.95 1 singlet Ar-NHh 
9i 10.03 1 singlet Ar-NHi 
10j 2.28 3 singlet Ar- CH3 
11k 9.46 1 singlet Ar-NH-CO 
12l+l’ 7.34-7.31 2 doublet Ar-Hk+k’ 
13m+m’ 7.49-7.52 2 doublet Ar-Hl+l” 
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 Figure 1.3: Mass spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl-2-Thio-N-phenyl-1,2,3,4-tetrahydropyrimidine-5-
 carboxamide: (NVT-01). 
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  INTRODUCTION 
 As mentioned in section-3, Biginelli disclosed a multicomponent 
reactions to the synthesis dihydropyrimidinones (DHPM)1. These derivatives 
are known to be interesting heterocyclic compounds for drug research2.  
Different methods have been reported for the synthesis of 
dihydropyrimidinones and its derivatives3-6 which have recently emerged as 
important target molecules due to their therapeutic and pharmacological 
properties7-8. Estrada has suggested computational approaches to design 
pyrimidyl nucleosides with anti-HIV activity 9. Nucleoside derivatives are well-
established today as effective antiviral agents in spite of the toxicity generally 
associated with them.10-14 Recently, few workers have reported a number of 
dihydropyridines to be adrenoceptor antagonists.15-18 
Deng et al. have synthesized dihydropyrimidinones in high yields by one-
pot cyclocondensation of three components19. Various workers have used 
ionic liquids as catalyst in Biginelli reaction for synthesized compounds.20-23 
Recently, many researchers have been improved several procedures for 
the preparation of DHPMs ( also known as Biginelli compounds).  Kappe et al. 
have synthesized dihydropyrimidine-2(1H)-one  using polyphosphate ester .24 
Hu et al. have used three component one pot condensation reaction for 
efficient synthesis.25 One pot synthesis of dihydropyrimidines-2(1H)-one have 
been reported by other workers.26,27 Bismuth and zeolite catalysized synthsis 
have also been reported by Ramalinga et al.28 and Rani et al.29 respectively. 
Lu et al.30 used lanthanum chloride as catalyst for one pot synthesis of 3,4-
dihydropyrimidin-2-ones. In some cases, methane sulfonic acid has been 
widely used as a catalysis for the synthesis,31,32 to have good color in final 
product, to increase the reaction rate, to avoid undesirable decomposition 
byproducts etc. Jin et al. have reported an efficient synthesis of 3,4-
dihydropyrimidin-2-ones from the aldehydes, b-ketoesters, and urea in 
ethanol using methanesulfonic acid as  catalyst.33 
In the present section, some new dihydropyrimidinones have been 
synthesized. 
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EXPERIMENTAL 
 
Synthesis of 4-(3,-methoxy4-ethoxyphenyl)-6-methyl-2-oxo-N-phenyl-
1,2,3,4-tetrahydropyrimidine-5-carboxamide. 
 
[A] Synthesis of 3,-methoxy4-ethoxy benzaldehyde: 
 
An aqueous solution of vanillin (0.01M) was refluxed at 95-97 0C for 
half an hour with stirring. To this solution, few drops of NaOH and diethyl 
sulphate (0.012 M) were added slowly and again the reaction mixture was 
refluxed for 5 to 7 hrs with stirring. The reaction was monitored by TLC. After 
the completion of reaction, organic layer was isolated and cooled at room 
temperature. The solid crude product was isolated and crystallized from 
absolute ethanol. (Scheme-1) 
 
[B] Synthesis of 3-oxo-N-phenylbutanamide: 
 
A mixture of substituted aniline (0.01 M) and ethyl acetoacetate (0.012 
M) in 40 ml toluene was refluxed for 12 hours in presence of few drops of 
slurry of NaOH in water. The reaction was monitoring with TLC. The excess of 
toluene was distilled out and the reaction mixture was taken in hexane and 
stirred with glass rod. The products were isolated in hexane and filtered. The 
crude product was dried. This product was  taken in aqueous NaOH solution 
and neutralized with dilute HCl. The recrystalisation was done in ethanol. 
(Scheme-2) 
 
[C] Synthesis of 4-(3,methoxy 4-ethoxyphenyl)-6-methyl-2-oxo-N-
  phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamide: 
A solution of 3-methoxy4-ethoxy aldehyde (0.01 M), substituted 
diketones (0.012 M) and urea (0.015 M) in methanol was refluxed for 12 hours 
in presence of few drops of concentrated HCl as catalyst. The product was 
isolated and crystallized from ethanol. All the synthesized compounds were 
recrystallized from ethanol.(Scheme-3) 
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Table 1.1: Physical constants of Dihydropyrimidinones. 
 
Sr. No. Code R M.F. M. Wt. (g/mol) 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 NVU-1 4-Cl- C21H22 ClN3O4 415 0.59 198 60 
2 NVU -2 3,4-Cl- C21H21 Cl2N3O4 450 0.54 182 52 
3 NVU -3 4-OCH3- C22H25 N3 O4 411 0.62 210 58 
4 NVU -4 3-Cl,4-F- C21H21 ClFN3O4 433 0.41 217 57 
5 NVU -5 3,4- CH3 C23H27 N3O4 409 0.43 223 43 
6 NVU -6 4-Cl- C21H22 ClN3O4 415 0.71 238 62 
7 NVU -7 4-F- C21H22 ClN3O4 399 0.57 198 54 
8 NVU -8 2-Cl,5-F - C21H21 ClFN3O4 433 0.59 232 62 
9 NVU -9 -H- C21H23N3O4 381 0.63 174 58 
10 NVU-10 2,4-Cl- C21H21 Cl2N3O4 450 0.49 189 45 
 
* Ethyl acetate:Hexane: 2:8 
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The characterization was done by IR, 1H NMR and mass spectra. 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
Spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. Figure 1.1 shows IR spectra of NVU-1. The IR spectral data for NVU-
1 is given in Table 1.2. The spectral data for all other compounds are reported 
in Table 1.3. 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 1.2 shows 
NMR spectra of NVU-1. The spectral data for NVU-1 is given in Table 1.4.  
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. Figure 
1.3 shows mass spectra of NVU-1The proposed mass fragmentation of the 
same compound is also given in Scheme 1.1. 
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Figure 1.1: IR spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl-
 2-oxo-N-phenyl- 1,2,3,4-tetrahydropyrimidine-5-carboxamide: (NVU-
 01). 
 
 
 
Table 1.2: IR spectral data of 4-(3,methoxy4-ethoxyphenyl)-6-
 methyl-2-oxo-N-phenyl-1,2,3,4-tetrahydropyrimidine-5-arboxamide: 
 (NVU-01). 
 
 
Type Vibration mode 
Frequency in cm-1 
Observed Reported 
Alkane 
C-H str. (asym.) 2933 2975-2900 
C-H str. (sym.) 2833 2880-2810 
C-H def. (asym.) 1450 1480-1435 
C-H def. (sym.) 1450 1985-1350 
Aromatic 
C-H str. 3006 3100-3000 
C=C str. 1508 1585-1480 
C-H i.p. def. 1122 1125-1090 
C-H o.o.p. def. 827 860-810 
Ketones C=O str.(cyclic) 1720 1740-1680 C=O str. (alip.) 1675 1710-1650 
Nitrogen 
C-N str. 1255 1350-1200 
N-H str. 3307 3400-3200 
N-H def. 1568 1650-1500 
Ether C-O-C str. (asym.) 1180 1400-1000 C-O-C str. (sym.) 1029 1075-1020 
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Table 1.3: IR spectral data of synthesized Dihydropyrimidinones. 
 
 
Compounds 
 
C=O 
(cyclic) 
C=O 
(alip.)
N-H 
C=C 
 
C=H 
(asym.) 
R 
NVU-1 1720 1675 3307 1508 2933 732 
NVU-2 1715 1664 3321 1537 2953 687 
NVU-3 1722 1673 3267 1529 2955 1123 
NVU-4 1720 1659 3309 1520 2912 762 
NVU-6 1711 1666 3261 1514 2967 758 
NVU-7 1707 1678 3286 1502 2972 633 
NVU-8 1720 1659 3309 1520 2912 762 
NVU-9 1714 1669 3269 1519 2967 759 
NVU-10 1709 1677 3285 1507 2962 671 
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Figure 1.2: 1H NMR spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl-2-oxo-N-phenyl-1,2,3,4-tetrahydropyrimidine-
 5-arboxamide: (NVU-01). 
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Table 1.4: 1H NMR spectral data of 4-(3,methoxy4-ethoxyphenyl)  -6-
 methyl-2-oxo-N-phenyl-1,2,3,4-tetrahydropyrimidine-5-arboxamide:
 (NVU-01). 
   
NH
N
H
NH
O
CH3
O
O
CH3
O
CH3
Cl
a
b
c
d e
f
g
h
ij
k
l
l'
m
m'
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons Multiplicity Inference 
1 1.33 3 singlet -CH3 
2 3.98 2 quartet -OCH2 
3 7.39 1 singlet Ar-Hc 
4 7.31 1 singlet Ar-Hd 
5 7.36 1 singlet Ar-H’e 
6 3.36 3 singlet -OCH3 
7 5.46 1 singlet Ar-Hg 
8 9.44 1 singlet Ar-Hh 
9 9.63 1 singlet Ar-HI 
10 2.19 3 singlet Ar- CH3 
11 8.10 1 singlet Ar-NH-CO 
12 7.57-7.62 2 doublet Ar-Hk+k’ 
13 7.36-7.49 2 doublet Ar-Hl+l” 
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Figure 1.3: Mass spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl-2-oxo-N-phenyl-1,2,3,4-tetrahydropyrimidine-5-
 carboxamide: (NVU-01). 
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  INTRODUCTION 
 Dihydropyrimidines, the synthetic potential of this new 
heterocyclic synthesis remained unexplored for quite some time. In the 1970s 
and 1980s interest slowly increased, and the scope of the original 
cyclocondensation reaction was gradually extended by variation of all three 
building blocks, allowing access to a large number of multifunctionalized 
dihydropyrimidines1 
In recent years interest has also focused on aza-analogs such as 
dihydropyrimidines (DHPMs) which show a very similar pharmacological 
profile to classical dihydropyridine calcium channel modulators 2,3. These  
asymmetric DHPM derivatives have not only very potent calcium channel 
modulators, but also have been studied extensively to expand the existing 
structure-activity relationships and to get further insight into molecular 
interactions at the receptor level 4-10. 
Over the past decade, anti-bacterial activity of of 2-amino-5-cyano-6-
hydroxy-4-aryl pyrimidines has been developed by Deshmukh et al.11 Yarım et 
al. have been reported structurel elucidation and pharmacological properties 
of some dihdro-pyrimidine-2(1H)-imino derivatives.12 Toshio et al. have 
reported  antihypertensive properties of 5-acetyl-2-halo-4,6- disubstituted-
pyrimidines as intermediates.13 The effect of tetrahydropyrimidine2(1H)-imino 
derivatives on cardiovascular system has been studied by Vitolina et al.14 
Gojkovic et al. have been reported a novel fungal catabolic pathway of 
5,6-dihydropyrimidine2(1H)-imino15 which have also repoted model organism 
for studying the catabolism of pyrimidines.16 Kautz et al. has also studied of 
dihydropyrimidine amidohydrolase from calf liver.17 Matsuda et al reported 
molecular cloning and sequencing of a cDNA encoding dihydropyrimidinase 
from the rat liver.18 Vogels et al. reported pyrimidines bases, several anti-
cancer drugs have been degraded via a reductive or an oxidative pathway 19. 
and pharmacokinetics studies of pyrimidine based drugs, like 5-fluorouracil 
have been achieved by Kubota et al.20 
Potapov et al.  have reported condensation of hetarylguanidines with 
aldehydes (Ketones) and dicarbonyl compounds.21Shaabani et al. have 
reported preparation 3,4-dihydropyrimidin- 2-(1H)-imino with NH4Cl as a 
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catalyst under neutral and solvent-free Conditions.22 Dondoni et al. have been 
studied synthesis of dihydropyrimidinyl and pyridyl R-amino Acids via three-
component Biginelli and Hantzsch cyclocondensations.23 Nilsson et al 
reported synthesis of Guanidine-containing heterocycles using the Biginelli 
reaction.24 Deshmukh et al. have been reported A green, simple and 
environmentally friendly approach towards one-step synthesis of 2,6-diamino-
4-phenyl pyrimidine-5-carbonitrile by three-component condensation by using 
potassium carbonate and in presence of tetrabutyl ammonium bromide.25 
In the present section, some new dihydro pyrimidine-imines have been 
synthesized. 
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     EXPERIMENTAL 
Synthesis of 4-(3,-methoxy4-ethoxyphenyl)-6-methyl-2-imino-N-phenyl-
1,2,3,4-tetrahydropyrimidine-5-carboxamide. 
 
[A] Synthesis of 3,-methoxy4-ethoxy benzaldehyde:  
An aqueous solution of vanillin (0.01M) was refluxed at 95-97 0C for 
half an hour with stirring. To this solution, few drops of NaOH and diethyl 
sulphate (0.012 M) were added slowly and again the reaction mixture was 
refluxed for 5 to 7 hrs with stirring. The reaction was monitored by TLC. After 
the completion of reaction, organic layer was isolated and cooled at room 
temperature. The solid crude product was isolated and crystallized from 
absolute ethanol. (Scheme-1) 
 
[B] Synthesis of 3-oxo-N-phenylbutanamide:  
A mixture of substituted aniline (0.01 M) and ethylacetoacetate (0.012 
M) in 40 ml toluene was refluxed for 12 hours in presence of few drops of 
slurry of NaOH in water. The reaction was monitoring with TLC. The excess of 
toluene was distilled out and the reaction mixture was taken in hexane and 
stirred with glass rod. The products were isolated in hexane and filtered. The 
crude product was dried. This product was  taken in aqueous NaOH solution 
and neutralized with dilute HCl. The recrystalisation was done in ethanol. 
(Scheme-2) 
 
[C] Synthesis of 4-(3,methoxy 4-ethoxyphenyl)-6-methyl-2- imino -
 N-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamide: 
 A solution of 3-methoxy4-ethoxy aldehyde (0.01 M), substituted 
diketones (0.012 M) and guanidine (0.015 M) in methanol was refluxed for 12 
hours in presence of few drops of concentrated HCl as catalyst. The product 
was isolated and crystallized from ethanol. All the synthesized compounds 
were recrystallized from ethanol.(Scheme-3) 
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Table 1.1: Physical constants of Dihydropyrimidinones. 
 
Sr. No. Code R M.F. 
M. Wt. 
(g/mol) 
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 NVG-1 4-Cl- C21H23 ClN4O4 414 0.34 199 59 
2 NVG-2 3,4-Cl- C21H22 Cl2N4O4 449 0.57 178 57 
3 NVG -3 4-OCH3- C22H25 N4 O4 410 0.61 230 67 
4 NVG -4 3-Cl,4-F- C21H22 ClFN4O4 432 0.43 223 57 
5 NVG -5 3,4- CH3 C23H28 N4O4 408 0.35 249 55 
6 NVG -6 4-Cl- C21H23ClN4O4 414 0.76 228 63 
7 NVG -7 4-F- C21H23 ClN4O4 398 0.42 196 57 
8 NVG -8 2-Cl,5-F C21H21 ClFN4O4 432 0.59 212 62 
9 NVG -9 H C21H24N4O4 380 0.63 144 51 
10 NVG-10 2,4-Cl- C21H22 Cl2N4O4 449 0.64 194 62 
* Ethyl acetate:Hexane: 2:8 
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The characterization was done by IR, 1H NMR and mass spectra. 
 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
Spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. Figure 1.1 shows IR spectra of NVG-1. The IR spectral data for NVG-
1 is given in Table 1.2. The spectral data for all other compounds are reported 
in Table 1.3. 
 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 1.2 shows 
NMR spectra of NVG-1. The spectral data for NVG-1 is given in Table 1.4.  
 
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. Figure 
1.3 shows mass spectra of NVG-1The proposed mass fragmentation of the 
same compound is also given in Scheme 1.1. 
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Figure 1.1: IR spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl-  
2- imino -phenyl- 1,2,3,4-tetrahydropyrimidine-5-carboxamide:  
(NVG-01). 
 
 
 
Table 1.2: IR spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl-2-   
imino -phenyl- 1,2,3,4-tetrahydropyrimidine-5-carboxamide:  
(NVG-01). 
 
Type Vibration mode 
Frequency in cm-1 
Observed Reported 
Alkane 
C-H str. (asym.) 2939 2975-2900 
C-H str. (sym.) 2842 2880-2810 
C-H def. (asym.) 1447 1480-1435 
C-H def. (sym.) 1427 1985-1350 
Aromatic 
C-H str. 3011 3100-3000 
C=Cstr. 1580 1585-1480 
C-H i.p. def. 1125 1125-1090 
C-H o.o.p. def. 841 860-810 
Ketones C=O str.(cyclic) 1710 1740-1680 C=O str. (alip.) 1684 1710-1650 
Nitrogen 
C-N str. 1258 1350-1200 
N-H str. 3315 3400-3200 
N-H def. 1583 1650-1500 
Ether C-O-C str. (asym.) 1189 1400-1000 C-O-C str. (sym.) 1036 1075-1020 
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 Table 1.3: IR spectral data of synthesized Dihydropyrimidinones. 
 
 
Compounds 
IR ૅ, (cm-1) 
C=O 
(cyclic) 
C=O 
(alip.)
N-H C=C 
 
C=H 
(asym.) R 
NVG-1 1710 1684 3315 1580 2939 734 
NVG-2 1707 1678 3286 1502 2972 633 
NVG-3 1722 1673 3267 1529 2955 1129 
NVG-4 1722 1669 3311 1529 2922 736 
NVG-6 1711 1666 3261 1514 2967 758 
NVG-7 1708 1679 3288 1522 2962 638 
NVG-8 1720 1659 3309 1520 2912 762 
NVG-9 1714 1670 3269 1519 2967 759 
NVG-10 1709 1677 3285 1507 2962 671 
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Figure 1.2: 1H NMR spectra of 4-(3,methoxy4-ethoxyphenyl)-6-methyl-2-imino-N-phenyl-1,2,3,4 tetrahydropyrimidine        
5-carboxamide: (NVG-01). 
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 Table 1.4: 1H NMR spectral data of 4-(3,methoxy4-ethoxyphenyl) 
 -6-methyl-2-imino-N-phenyl-1,2,3,4-tetrahydropyrimidine-5-
 carboxamide: (NVG-01). 
   
NH
N
H
NH
O
CH3
O
O
CH3
NH
CH3
Cl
a
b
c
d e
f
g
h
i
j
k
l
m
m'
n
n'
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No. 
of Protons Multiplicity Inference 
1a 1.26 3 singlet -CH3 
2b 3.81 2 quvartret -OCH2 
3c 7.39 1 doublet Ar-Hc 
4d 7.31 1 doublet Ar-Hd 
5e 7.36 1 singlet Ar-H’e 
6f 3.35-3.52 3 singlet -OCH3 
7g 5.46 1 singlet Ar-Hg 
8h 8.10 1 singlet Ar- NH- 
9i 9.66-9.82 1 singlet Ar NH- 
10j 10.48-10.58 1 singlet Ar NH- 
11k 3.36 3 singlet Ar-CH3 
12l 8.72 1 singlet Ar-NH-CO 
13m 7.57-7.62 2 doublet Ar-Hk+k’ 
14n 7.27-7.33 2 doublet Ar-Hl+l” 
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Figure 1.3: Mass spectra of 4-(3-methoxy4-ethoxyphenyl)-6-methyl-2-imino-N-phenyl-1,2,3,4-tetrahydropyrimidine-5-
carboxamide: (NVG-01). 
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     INTRODUCTION 
 “Ultrasound” refers to sound waves of such a high frequency that it cannot 
be heard. These waves are also known as silent sound waves having 
frequencies beyond the range of human hearing i.e. above 20 KHz (20,000 
cycles per second). However, bats, dogs can hear these waves. Bats use 
ultrasounds to move in darkness and also for searching food. Dolphins and some 
other whales also use the ultrasounds as a hunting tool. 
Now a day’s Ultrasonic technology is employed in a wide range of 
applications in medicine, biology, industry, material science, agriculture, ocean- 
ography, sonochemistry   research etc. due to its non-destructive nature 1-8.  
 High resolution ultrasound imaging has been used for determination of 
melanoma invasion depth in vivo for preoperative staging purposes 9-10. 
Ultrasonography provides a wide array of morphologic information without 
invading or disturbing the tissues. The research potential of this technology and 
its adaptability for computer-assisted assessment go far beyond simplistic 
determination of ovulation, luteal formation, pregnancy diagnosis, 
radioimmunoassay 11-13 etc. Further, these waves have applications in 
angiography 14-16, echocardiography 17-19 and magnetic resonance imaging 
techniques.20-21  
 Further, these ultrasound waves have been employed for the treatment of 
several diseases, including thromboembolism, arteriosclerosis, cancer, 
Cardiovascular, calcific tendinitis of the shoulder and gene delivery applications 
22-27. Recently, ultrasound is used for making tablets from pharmaceutical 
powders.  
 In the metallurgy, these ultrasonic waves are used for corrosion study, 
electroplating 28, galvanizing 29, metal degreasing 30 ultrasonic welding for joining 
of metals. 31 These waves also have applications in plastic and ceramic 
industries. 32-35 Ultrasound wave’s applications in continuous culture have been 
great potential for the biotechnological techniques 36-44.  These waves have also 
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been used to extract and release intracellular enzymes such as invertase, to 
promote enzyme release, enhance productivity in biological processes 45 etc.  
  In field of agriculture, ultrasound waves have been utilized extensively in 
chemical additives (fertilizers and plant protection preparations) for improving the 
production yield of food produced. Further, it is used to study the substitution of 
chemical fertilizers and soil additives with alternative treatment methods, such as 
irradiation, measure composition traits in live cattle and the use of 
electromagnetic energy. 46-49. It is also applied for inactivation of micro-organisms 
in food and dairy industry 50-52. In materials chemistry, ultrasound waves have 
been useful in the preparation of biomaterials, protein microspheres, in the 
modification of polymers and polymer surfaces etc 53-58. 
 Recently, ultrasound radiations are used in synthetic organic chemistry, 
which causes a decrease of reaction time, increase of yield, lower reaction 
temperature, avoidance of phase transfer catalysis etc 59-64. Further, ultrasonic 
velocity measurements have been used to study the nature of molecular 
interactions in various binary 65-75 and ternary 76-81 liquid mixtures. Much work has 
been done in solutions of polymers 82-87, pharma materials 88-91, amino acids 92-93 
and other electrolytes 94-100 and non-electrolytes 101-105. However, little work has 
been done for solutions of solid organic compounds 106-111.  
 Thus, in the present chapter, acoustical studies of some synthetic 
chalcones of vanillin derivatives have been studied in DMF and Chloroform at 
303.15 K over a wide range of concentrations. 
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    EXPERIMENTAL 
 The selected solvents DMF and Chloroform for the present study are 
distilled by the reported procedure112. The synthesized Chalcones were 
recrystallized before use. 
 The densities and ultrasonic velocities of solvents and solutions of 
Chalcones of different concentrations were measured at 303.15 K by using 
pyknometer and single frequency ultrasonic interferometer operating at 2 MHz, 
with the uncertainties of 0.0001 g/cm3 and 0.01% respectively. 
Density measurements: 
              The weight of distilled water, pure solvents and solutions of Chalcone of 
vanillin derivatives were measured by using pyknometer. The densities (ρ) were 
evaluated by using following equation: 
( ) ( )( )( )3 wt. of solvent or solution density of waterρ g cm = wt. of water         … (3.1.1) 
Viscosity Measurements: 
           To determine the viscosity of solution, Ubbelohde viscometer (113) was 
used, which obeys Stoke’s low. The measured quantity of the distilled water / 
solvent / solution was placed in the viscometer, which was suspended in a 
thermostat at 298.15 K. The digital stopwatch, with an accuracy of + 0.01 sec 
was used to determine flow time of solutions. Using the flow times (t) and known 
viscosity of standard water sample, the viscosity of solvent and solutions were 
determined according to equation: 
    1 1 1
2 2 2
t
t
η ρ
η ρ=                                       ... (3 .1.2) 
Sound velocity measurement: 
          Ultrasonic interferometer,(Mittal Enterprise, New Delhi, Model No. F-81) 
working at frequency of 2 MHz was used to determine sound velocity. 
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         The solvent / solution were filled in the measuring cell with quartz crystal 
and then micrometer was fixed. The circulation of water from the thermostat at 
303.15 K was started and test solvent / solution in the cell is allowed to thermally 
equilibrate. The micrometer was rotated very slowly so as to obtain a maximum 
or minimum of anode current (n). A number of maximum reading of anode 
current were counted. The total distance (d) travel by the micrometer for n=10, 
was read. The wave length (λ) was determined according to the equation (3.1.3). 
                                           2d
n
λ =         … (3.1.3)               
The sound velocity (U) of solvent and solutions were calculated from the 
wavelength and frequency (F) according to equation (3.1.4). 
     U Fλ=                 ... (3.1.4) 
where, F= 2 × 106 Hertz. 
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    RESULTS AND DISCUSSION 
         Table 3.1.1 shows the experimental data of density (ρ), viscosity and sound 
velocity (U) of pure solvents and solutions of synthesized Chalcones in DMF and 
Chloroform at 303.15 K.  
         From these experimental data, various acoustical parameters were 
evaluated using the following equations: 
1.  Isentropic compressibility: 
         Isentropic compressibility ( sκ ) was evaluated by Krishnamurty et al.113:  
     2
1
s U
κ ρ=     … (3.1.5) 
2.  Intermolecular free path length: 
 The intermolecular free path length (Lf), was calculated by equation
114: 
     1 2f j sL K κ=       … (3.1.6) 
where KJ is Jacobson constant (=2.0965 X 10
-6)   
3.  Molar compressibility: 
          Molar compressibility (W) can be calculated by the following equation
115
: 
     1 7s
MW κρ
−⎛ ⎞= ⎜ ⎟⎝ ⎠
   … (3.1.7) 
The apparent molecular weight (M) of the solution can be calculated as: 
     1 1 2 2M MW M W= +    … (3.1.8) 
where W1 and W2 are weight fractions of solvent and solute, respectively. M1 
and M2 are the molecular weights of the solvent and compounds respectively.  
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4.  Rao’s molar sound function: 
          Rao’s molar sound function (Rm) can be evaluated by an equation given 
by Bagchi et al.
116
: 
              1 3m
MR Uρ
⎛ ⎞= ⎜ ⎟⎝ ⎠
                         … (3.1.9) 
  5.  Van der Waals Constant: 
          Van der Waals constant (b) can be calculated as follows 117: 
           
2
21 1 13
M RT MUb
MU RTρ
⎧ ⎫⎡ ⎤⎪ ⎪⎛ ⎞= − + −⎢ ⎥⎨ ⎬⎜ ⎟⎝ ⎠ ⎢ ⎥⎪ ⎪⎣ ⎦⎩ ⎭
   ... (3.1.10) 
where R is the gas constant (=8.3143 JK-1 mol-1) and T is the absolute 
temperature. 
6.  Relaxation Strength: 
          The relaxation strength (r) can be calculated as follows 118: 
    
2
1r U
U
= −
∞
⎡ ⎤⎢ ⎥⎣ ⎦
                                   … (3.1.11) 
where ∞U  = 1.6 x 105 cm.s
-1 
7. Solvation number:  
                                    
2
1 1
1 100s
n
s
M XS
M X
κ
κ
⎡ ⎤− −⎡ ⎤= ⎢ ⎥ ⎢ ⎥⎣ ⎦⎣ ⎦                    … (3.1.12) 
where X is the number of grams of solute in 100 gm of the solution. M1 and M2 
are the molecular weights and κS1 and κS are isentropic compressibility of solvent 
and solute respectively. 
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Table 3.1.1: The density (ρ), ultrasonic velocity (U) and viscosity (η) of  
 chalcone of vanillin derivatives in DMF and chloroform at 303.15 K. 
 
Conc. 
M 
 
 
Density 
ρ 
g.cm-3 
Velocity 
U. 10-5 
cm.s-1 
 
Viscosity 
η.103 
poise 
 
Density 
ρ 
g.cm-3 
Velocity 
U. 10-5 
cm.s-1 
 
Viscosity 
η.103 
poise 
 
 DMF Chloroform 
 NVA-1 NVA-1 
0.00 0.9417 1.4388 5.7887 1.4748 0.9696 4.2657 
0.01 0.9430 1.4444 6.7031 1.47481 0.9712 4.4573 
0.02 0.9438 1.4448 6.7998 1.47492 0.9730 4.4754 
0.04 0.946 1.4468 7.7111 1.47525 0.9744 4.5120 
0.06 0.9482 1.4472 8.0514 1.47547 0.9760 4.5152 
0.08 0.9493 1.4484 8.4512 1.47575 0.9784 4.5364 
0.10 0.9512 1.4492 8.6957 1.47612 0.9831 4.5528 
 NVA-2 NVA-2 
0.01 0.9424 1.4416 5.9300 1.4783 0.9694 4.4755 
0.02 0.9427 1.4420 6.0617 1.4786 0.9708 4.4942 
0.04 0.944 1.4424 6.1245 1.4753 0.9732 4.5198 
0.06 0.9455 1.4440 6.1831 1.4757 0.9768 4.5235 
0.08 0.9456 1.4456 6.2415 1.47608 0.9792 4.5450 
0.10 0.9468 1.4464 6.3309 1.4763 0.9818 4.5609 
 NVA-3 NVA-3 
0.01 0.9422 1.4424 5.8534 1.47496 0.9697 4.4895 
0.02 0.9432 1.4432 5.9756 1.47548 0.9702 4.5089 
0.04 0.9426 1.4436 6.1154 1.47596 0.9715 4.5459 
0.06 0.9445 1.4444 6.2529 1.47648 0.9754 4.5501 
0.08 0.9458 1.4448 6.3209 1.4769 0.9770 4.5717 
0.10 0.9461 1.4460 6.3751 1.47722 0.9798 4.5879 
 NVA-4 NVA-4 
0.01 0.9429 1.4396 6.0305 1.47638 0.9698 4.5104 
0.02 0.9431 1.4404 6.4214 1.47666 0.9707 4.5290 
0.04 0.9443 1.4412 6.7278 1.47713 0.9730 4.5660 
0.06 0.9453 1.4420 6.8952 1.47753 0.9754 4.5698 
0.08 0.9474 1.4432 7.1380 1.47792 0.9780 4.5914 
0.10 0.9476 1.4456 7.2121 1.47814 0.9820 4.6073 
 NVA-5 NVA-5 
0.01 0.9418 1.4396 5.8971 1.47531 0.9700 4.4639 
0.02 0.9429 1.4400 5.9591 1.47559 0.9705 4.4826 
0.04 0.9437 1.4412 6.0519 1.47606 0.9722 4.5196 
0.06 0.9447 1.4424 6.1599 1.47646 0.9747 4.5233 
0.08 0.9463 1.4436 6.2209 1.47682 0.9771 4.5448 
0.10 0.9464 1.4448 6.2419 1.47704 0.9799 4.5607 
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Conc. 
M 
 
 
Density 
ρ 
g.cm-3 
Velocity 
U. 10-5 
cm.s-1 
 
Viscosity 
η.103 
poise 
 
Density 
ρ 
g.cm-3 
Velocity 
U. 10-5 
cm.s-1 
 
Viscosity 
η.103 
poise 
 
 DMF Chloroform 
 NVA-6 NVA-6 
0.00 0.9417 1.4388 5.7887 1.47541 0.9735 4.5430 
0.01 0.9422 1.4436 5.9417 1.47573 0.9740 4.5579 
0.02 0.9433 1.4448 5.9982 1.4762 0.9753 4.5784 
0.04 0.9445 1.4488 6.0790 1.47668 0.9755 4.6295 
0.06 0.9458 1.4496 6.2086 1.4771 0.9771 4.6498 
0.08 0.9473 1.4504 6.3114 1.47736 0.9785 4.6710 
0.10 0.9476 1.4508 6.3477 1.47541 0.9735 4.5430 
 NVA-7 NVA-7 
0.01 0.9445 1.4460 6.1651 1.47555 0.9684 4.4875 
0.02 0.9449 1.4500 6.2710 1.47596 0.9686 4.5027 
0.04 0.9479 1.4532 6.5356 1.47644 0.9701 4.5169 
0.06 0.9489 1.4568 6.7900 1.47692 0.9734 4.5374 
0.08 0.9503 1.4612 6.9038 1.47738 0.9743 4.5643 
0.10 0.9543 1.4628 7.1169 1.47761 0.9796 4.6324 
 NVA-8 NVA-8 
0.01 0.9461 1.4464 6.0469 1.47504 0.9678 4.5164 
0.02 0.9461 1.4508 6.1976 1.47538 0.9688 4.5314 
0.04 0.9471 1.4568 6.4258 1.47606 0.9715 4.5526 
0.06 0.9491 1.4600 6.7800 1.47658 0.9754 4.6037 
0.08 0.9507 1.4616 7.0589 1.4769 0.9770 4.6238 
0.10 0.9516 1.4640 7.9042 1.47722 0.9798 4.6451 
 NVA-9 NVA-9 
0.01 0.9434 1.4424 6.0086 1.47559 0.9690 4.5118 
0.02 0.9441 1.4444 6.0496 1.47608 0.9700 4.5272 
0.04 0.9447 1.4456 6.0827 1.47646 0.9727 4.5475 
0.06 0.9454 1.4468 6.1336 1.47728 0.9766 4.5996 
0.08 0.9462 1.4476 6.2243 1.4785 0.9782 4.6224 
0.10 0.9474 1.4488 6.3912 1.47882 0.9810 4.6438 
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Some of these calculated parameters are given in Table 3.1.2 for chalcones in 
DMF and Chloroform respectively. Figure 3.1.1 shows the variation of ultrasound 
velocity (U) with concentration in DMF and Chloroform. It is observed that overall 
ultrasonic velocity (U) increases with concentration for all the compounds in both 
the solvents. The velocity depends on intermolecular free length (Lf). The velocity 
increases with decrease in Lf or vice versa. It is evident from Table 3.1.2 that Lf 
decreases continuously, which suggests that there is strong interaction between 
solvent (both DMF and Chloroform) and compound molecules. 
 This is further supported by isentropic compressibility (κs) and relaxation 
strength (r) values. The variation of isentropic compressibility (κs) with 
concentration of these compounds is also shown Figure 3.1.2 for all the solutions 
in both the solvents. Both isentropic compressibility (κs) and relaxation strength 
(r) (in Table 3.1.2) are observed to decrease with concentration for all the 
compounds. The decrease of κs with increasing concentration might be due to 
aggregation of solvent molecules around solute molecules indicating thereby the 
presence of solute-solvent interactions.  
 Figure 3.1.3 shows the linear variation of molar compressibility (W) with 
concentration whereas Table 3.1.2 shows the variation of molar sound function 
(Rm) and Vander Waals constant (b) with concentration. The correlation 
coefficients for these parameters are in the range of 0.9989- 0.9999. This linear 
increase of these parameters suggests the absence of complex formation in 
these systems.  
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Table 3.1.2: Some acoustical parameters of chalcones in DMF and chloroform at 
303.15 K.   
Conc. 
M 
Lf 
Ao r 
Rm.10-3
cm8/3 
.s-1/3 
b 
cm3.mol-1 
Lf 
Ao r 
Rm.10-3 
cm8/3 
.s-1/3 
b 
cm3.mol-1 
DMF Chloroform 
NVA-1 NVA-1 
0.00 0.1502 0.1913 4.0670 77.6131 0.1780 0.6328 3.7225 81.0257 
0.01 0.1495 0.1850 4.1120 78.3705 0.1778 0.6316 3.7376 81.3111 
0.02 0.1494 0.1846 4.1542 79.1661 0.1774 0.6302 3.7529 81.5909 
0.04 0.1490 0.1823 4.2364 80.6957 0.1771 0.6291 3.7801 82.1439 
0.06 0.1488 0.1819 4.3163 82.2103 0.1768 0.6279 3.8079 82.7028 
0.08 0.1486 0.1805 4.4018 83.8148 0.1764 0.6260 3.8366 83.2579 
0.10 0.1483 0.1796 4.4823 85.3328 0.1755 0.6225 3.8681 83.8072 
NVA-2 NVA-2 
0.01 0.1498 0.1882 4.1158 78.3607 0.1779 0.6329 3.7277 81.1451 
0.02 0.1497 0.1877 4.1639 79.5521 0.1776 0.6319 3.7430 81.4397 
0.04 0.1496 0.1873 4.2564 81.9877 0.1774 0.6300 3.7834 82.2482 
0.06 0.1493 0.1855 4.3485 84.3850 0.1767 0.6273 3.8157 82.8502 
0.08 0.1491 0.1837 4.4473 86.7819 0.1762 0.6255 3.8466 83.4527 
0.10 0.1490 0.1828 4.5395 89.1708 0.1757 0.6235 3.8782 84.0640 
NVA-3 NVA-3 
0.01 0.1497 0.1873 4.1032 78.2372 0.1780 0.6327 3.7319 81.2282 
0.02 0.1496 0.1864 4.1370 78.8685 0.1779 0.6323 3.7409 81.4106 
0.04 0.1496 0.1859 4.2044 80.1451 0.1776 0.6313 3.7608 81.8059 
0.06 0.1494 0.1850 4.2687 81.3553 0.1769 0.6284 3.7838 82.1984 
0.08 0.1492 0.1846 4.3322 82.5585 0.1766 0.6271 3.8043 82.5961 
0.10 0.1491 0.1832 4.4012 83.8502 0.1761 0.6250 3.8264 82.9991 
NVA-4 NVA-4 
0.01 0.1500 0.1904 4.1016 78.2582 0.1779 0.6326 3.7298 81.1793 
0.02 0.1499 0.1895 4.1405 78.9851 0.1777 0.6319 3.7413 81.4041 
0.04 0.1497 0.1886 4.2136 80.3662 0.1773 0.6302 3.7652 81.8583 
0.06 0.1495 0.1877 4.2874 81.7583 0.1768 0.6283 3.7893 82.3158 
0.08 0.1492 0.1864 4.3559 83.0409 0.1763 0.6264 3.8137 82.7733 
0.10 0.1490 0.1837 4.4346 84.4952 0.1756 0.6233 3.8405 83.2403 
NVA-5 NVA-5 
0.01 0.1502 0.1904 4.1115 78.4477 0.1779 0.6324 3.7345 81.2746 
0.02 0.1501 0.1900 4.1511 79.1961 0.1778 0.6321 3.7471 81.5359 
0.04 0.1499 0.1886 4.2367 80.8065 0.1775 0.6308 3.7735 82.0629 
0.06 0.1497 0.1873 4.3211 82.3927 0.1770 0.6289 3.8012 82.5932 
0.08 0.1495 0.1859 4.4021 83.9147 0.1766 0.6270 3.8288 83.1253 
0.10 0.1493 0.1846 4.4904 85.5744 0.1760 0.6249 3.8573 83.6651 
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Conc. 
M 
Lf 
Ao r 
Rm.10-3 
cm8/3 
.s-1/3 
b 
cm3.mol-1 
Lf 
Ao r 
Rm.10-3 
cm8/3 
.s-1/3 
b 
cm3.mol-1 
DMF Chloroform 
NVA-6 NVA-6 
0.00 0.1502 0.1859 4.1239 78.6107 0.1780 0.6328 3.7225 81.0257 
0.01 0.1496 0.1846 4.1745 79.5541 0.1773 0.6298 3.7421 81.3428 
0.02 0.1494 0.1801 4.2815 81.5177 0.1772 0.6294 3.7580 81.6756 
0.04 0.1489 0.1792 4.3844 83.4616 0.1769 0.6284 3.7907 82.3498 
0.06 0.1487 0.1783 4.4858 85.3748 0.1769 0.6283 3.8220 83.0226 
0.08 0.1485 0.1778 4.5925 87.3990 0.1765 0.6270 3.8552 83.6980 
0.10 0.1484 0.1859 4.1239 78.6107 0.1763 0.6260 3.8885 84.3821 
NVA-7 NVA-7 
0.01 0.1502 0.1832 4.1230 78.5496 0.1782 0.6337 3.7375 81.3855 
0.02 0.1492 0.1787 4.1862 79.6814 0.1782 0.6335 3.7551 81.7635 
0.04 0.1487 0.1751 4.2974 81.7382 0.1779 0.6324 3.7926 82.5377 
0.06 0.1482 0.1710 4.4178 83.9587 0.1772 0.6299 3.8325 83.3108 
0.08 0.1477 0.1660 4.5366 86.1295 0.1770 0.6292 3.8692 84.0840 
0.10 0.1472 0.1641 4.6376 88.0154 0.1761 0.6251 3.9125 84.8702 
NVA-8 NVA-8 
0.01 0.1492 0.1828 4.1040 78.1817 0.1784 0.6341 3.7340 81.3251 
0.02 0.1487 0.1778 4.1570 79.1112 0.1782 0.6333 3.7487 81.6188 
0.04 0.1482 0.1710 4.2559 80.8809 0.1776 0.6313 3.7792 82.2052 
0.06 0.1477 0.1673 4.3469 82.5499 0.1769 0.6284 3.8115 82.7997 
0.08 0.1472 0.1655 4.4376 84.2428 0.1766 0.6271 3.8416 83.4050 
0.10 0.1467 0.1628 4.5324 85.9938 0.1761 0.6250 3.8730 84.0097 
NVA-9 NVA-9 
0.01 0.1502 0.1873 4.1027 78.2281 0.1781 0.6332 3.7310 81.2273 
0.02 0.1496 0.1850 4.1411 78.9232 0.1779 0.6324 3.7423 81.4450 
0.04 0.1494 0.1837 4.2185 80.3776 0.1774 0.6304 3.7673 81.9133 
0.06 0.1492 0.1823 4.2954 81.8192 0.1766 0.6275 3.7926 82.3561 
0.08 0.1490 0.1814 4.3711 83.2469 0.1763 0.6262 3.8141 82.7749 
0.10 0.1489 0.1801 4.4450 84.6308 0.1757 0.6241 3.8393 83.2443 
 
 
 
 
 
 Studies of some bio active hetero……. 
                                                                           Section-I: Acoustical property 
  94 
 
Figure 3.1.1: Variation of ultrasonic velocity (U) of chalcones (NVA) with concentration in [A] DMF and [B] 
chloroform at  303.15 K. 
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Figure 3.1.2: Variation of Isentropic compressibility (κs) of chalcones (NVA) with concentration in [A] DMF 
and  [B] chloroform at 303.15 K. 
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Figure 3.1.3: Variation of Molar compressibility (W) of chalcones (NVA) with concentration in [A] DMF and 
[B] chloroform at 303.15 K. 
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Figure 3.1.4: Variation of Solvation Number (Sn)of chalcones (NVA) with concentration in [A] DMF and [B] 
chloroform at  303.15 K. 
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 The solvation number is a measure of structure forming or structure 
breaking tendency of a solute in solutions. Figure 3.1.4 shows the variation of 
solvation number (Sn) with concentration and Sn values are positive for both the 
solvents. However, values are higher in DMF that those in Chloroform. As 
evident from Fig.3.1.4 that in DMF, Sn values increases continuously with 
concentration for all the studied compounds. Whereas in Chloroform are 
observed to decreases with concentration except for NVA-6. This suggest that in 
DMF, structure forming tendency continuously with concentration of compounds 
but in Chloroform, as compound concentration increases structure forming 
tendency decreases, although solute-solute interaction still exist.  
 Thus, it is concluded that in both DMF and Chloroform solutions of 
Chalcones exhibit solute-solvent interactions exist. 
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    INTRODUCTION 
 The refractive index is a unitless number, between 1.3000 and 1.7000 
for most compounds, and is normally determined to five digit precision 1. 
Since the index of refraction depends on both the temperature of the sample 
and the wavelength of light. The refractive index is commonly determined as 
part of the characterization of liquid samples, in much the same way that 
melting points are routinely obtained to characterize solid compounds. It is 
also commonly used to help identify or confirm the identity of a sample by 
comparing its refractive index to known values and assess the purity of a 
sample by comparing its refractive index to the value for the pure substance. 
It is one of the physical constants that can be used to describe a chemical 
species. Further, it is useful for the identification of crystalline substance.  
Refractive Index along with density, molecular mass and specific 
volume is very useful in the evaluation of various thermodynamics properties 
of chemical materials. The number of atoms, groups, radicals and bonds 
present in the compound can also be calculated by refractive index 
measurement. 
 A refractometer measures the extent to which light is bent (i.e. 
refracted) when it moves from air into a sample and is typically used to 
determine the index of refraction or refractive index of a liquid sample. 
 The most popular use of refractometer is to determine the percentage 
of sugar 2-6, liquid mixture 7-9, liquid crystals 10-11, and determination of film 
thickness 12-14 etc. The inter-dependence between refractive index and density 
of inorganic solids has been investigated 15-19. 
 In the present section, the refractive index of solutions of Chalcones 
has been measured in dimethyl formamide and Chloroform at 303.15 K.  
From the experimental data, the density and refractive index of the 
compounds have been evaluated. 
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     EXPERIMENTAL 
The solvents DMF and Chloroform were purified by fractionally 
distillation by the reported method 20. For each compound, a series of 
solutions of different concentrations were prepared in these solvents.   
  The density and refractive index of pure solvents and solutions were 
measured by using pycnometer and Abbe Refractometre respectively at 
303.15 K. The temperature was maintained by circulating water through jacket 
around the prisms of Refractometre from an electronically controlled 
thermostatic water bath (NOVA NV-8550 E). The uncertainty of temperature 
was ± 0.1 oC and that of density and refractive index was ±0.0001 g/cm3 and 
0.0005 respectively. 
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   RESULTS AND DISCUSSION 
 Table 3.2.1 shows the experimental values of densities and refractive 
index for all the studied solutions.  From the experimental values of density of 
solution, density of solid compound is evaluated by the following equation: 
                           1 2
12 1 2
1 g g
ρ ρ ρ= +         … (3.2.1) 
where ρ12 is the density of solution and ρ1 and ρ2 are the densities of solvent 
and solute respectively. g1 and g2 are the weight fractions of solvent and 
solute respectively. 
Figure 3.2.1 shows the plot of 1 121 g ρ  verses 2 1g g  for NVA-1 in DMF 
and Chloroform respectively. The inverse of slope of plot gives the density of 
compound ( 2ρ ). The densities of all the compounds evaluated from such plots 
are given in Table 3.2.2 for Chalcones respectively in DMF and Chloroform. 
These density values of compounds can also be theoretically evaluated by 
using the following equation (3.2.2),        
                            A iKM N Vρ = Δ∑                       … (3.2.2) 
where ρ is the density of the compound, K is packing fraction (0.599), M is the 
molecular weight of the compound, NA is the Avogadro’s number and ∆Vi is 
the volume increment of the atoms and atomic groups present in the 
compound. These theoretical values of density are reported in Table 3.2.2. 
The calculated volume increment ∆Vi for different atomic groups are given in 
Table 3.2.3. 
Comparison of densities evaluated from graphs and those calculated 
from eq. (3.2.2) showed that calculated values are different from those 
evaluated graphically. Further, for the same compound, density in the two 
solvents is different. This suggests that solvent plays an important role. In 
solutions molecular interactions exist which differ in different solvents. These 
interactions differ due to different substitutions in compounds. The presence 
of these interactions has also observed in ultrasonic studies which are 
discussed in section I of chapter 2. Due to these interactions there may be 
some changes in volume which affects density. 
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Table 3.2.1: The density (ρ12) and refractive index (n) of chalcones in 
DMF and chloroform at 303.15K. 
 DMF Chloroform 
Conc. 
M 
ρ12 
g.cm-3 n 
ρ12 
g.cm-3 n 
 NVA-1 NVA -1 
0.00 0.9417 1.4271 1.4748 1.436 
0.01 0.9430 1.4295 1.47481 1.4371 
0.02 0.9438 1.4300 1.47492 1.4392 
0.04 0.9460 1.4305 1.47525 1.4403 
0.06 0.9482 1.4315 1.47547 1.4417 
0.08 0.9493 1.4320 1.47575 1.4429 
0.10 0.9512 1.4325 1.47612 1.4475 
 NVA -2 NVA -2 
0.01 0.9424 1.4289 1.47484 1.4365 
0.02 0.9427 1.4299 1.47486 1.4371 
0.04 0.9440 1.4309 1.4753 1.4392 
0.06 0.9455 1.4322 1.4757 1.4403 
0.08 0.9456 1.4335 1.47608 1.4417 
0.10 0.9468 1.4356 1.4763 1.4429 
 NVA -3 NVA -3 
0.01 0.9422 1.4283 1.47496 1.4406 
0.02 0.9426 1.4290 1.47548 1.4427 
0.04 0.9432 1.4308 1.47596 1.4438 
0.06 0.9445 1.4313 1.47648 1.4452 
0.08 0.9458 1.4326 1.4769 1.4464 
0.10 0.9461 1.4338 1.47722 1.451 
 NVA -4 NVA -4 
0.01 0.9429 1.4276 1.47638 1.4446 
0.02 0.9431 1.4282 1.47666 1.4457 
0.04 0.9443 1.4287 1.47713 1.4471 
0.06 0.9453 1.4305 1.47753 1.4483 
0.08 0.9474 1.4311 1.47792 1.4529 
0.10 0.9476 1.4319 1.47814 1.4531 
 NVA -5 NVA -5 
0.01 0.9418 1.4292 1.47531 1.4386 
0.02 0.9429 1.4299 1.47559 1.4392 
0.04 0.9437 1.4311 1.47606 1.4413 
0.06 0.9447 1.4323 1.47646 1.4424 
0.08 0.9463 1.4334 1.47682 1.4438 
0.10 0.9464 1.4345 1.47704 1.445 
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Conc. 
M 
ρ12 
g.cm-3 n 
ρ12 
g.cm-3 n 
 NVA -6 NVA -6 
0.00 0.9422 1.4280 1.4748 1.436 
0.01 0.9433 1.4290 1.4754 1.4506 
0.02 0.9445 1.4297 1.4757 1.4512 
0.04 0.9458 1.4305 1.4762 1.4533 
0.06 0.9473 1.4320 1.4766 1.4544 
0.08 0.9476 1.4343 1.4771 1.4558 
0.10 0.9422 1.4280 1.4773 1.457 
 NVA -7 NVA -7 
0.01 0.9445 1.4276 1.4755 1.4400 
0.02 0.9449 1.4278 1.4759 1.4421 
0.04 0.9479 1.4281 1.4764 1.4432 
0.06 0.9489 1.4288 1.4769 1.4446 
0.08 0.9503 1.4303 1.4773 1.4458 
0.10 0.9543 1.4308 1.4776 1.4504 
 NVA-8 NVA-8 
0.01 0.9461 1.4284 1.4750 1.4382 
0.02 0.9471 1.4296 1.4753 1.4403 
0.04 0.9479 1.4308 1.4760 1.4414 
0.06 0.9491 1.4320 1.4765 1.4428 
0.08 0.9507 1.4334 1.4769 1.4440 
0.10 0.9516 1.4348 1.4772 1.4486 
 NVA-9 NVA-9 
0.01 0.9434 1.4285 1.4755 1.4385 
0.02 0.9441 1.4296 1.4760 1.4406 
0.04 0.9447 1.4312 1.4764 1.4417 
0.06 0.9454 1.4324 1.4772 1.4431 
0.08 0.9462 1.4338 1.4785 1.4443 
0.10 0.9474 1.4349 1.4788 1.4489 
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Figure 3.2.1: The variation of 1/g1ρ12 with g2/g1 for NVA-1 in [A]  DMF and  
                       [B] chloroform at 303.15 K. 
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Table 3.2.2: Experimental and calculated densities of chalcones in  
           DMF and chloroform Solutions at 303.15 K. 
Compounds 
Density (g.cm-3) from Figure 3.2.1 
 Density (g.cm-3) 
from Eqn. 3.2.2 DMF Chloroform 
NVA-1 1.3441 1.5408 1.2478 
NVA-2 1.1161 1.5552 1.3513 
NVA-3 1.1287 1.6207 1.2501 
NVA -4 1.1820 1.6287 1.1770 
NVA -5 1.1287 1.6313 1.2510 
NVA -6 1.1534 1.5898 1.2343 
NVA -7 1.3587 1.5924 1.4364 
NVA -8 1.2563 1.5974 1.3417 
NVA -9 1.1274 1.7007 1.3018 
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Table 3.2.3: Volume increments of some atoms and groups of atoms. 
Atoms or 
Atomic group 
Volume 
Increments (Ao)3
Atoms or 
Atomic group 
Volume 
Increments 
(Ao)3 
CH
C
C
1 4.
 
 
 
14.7 
 
C Cl
1 77.
 
 
19.35 
C
C
C
C
. 1 54.1 34
 
 
9.0 
 
C O H
1 37.
 
 
5.36 
 
C
C
C
N
1 37. 1 4.
 
 
 
10.2 
 
 
C Br 
 
 
11.20 
 
C
C
C
O
 
11.65 
 
BrC  
14.29 
C
C
C
H
1 08. 1 48.
1 28.
 
 
 
11.36 
 
N
O
O
C 1 21.
1 57.   
7.46 
 
C
C
H
HH
1 541 54. .
 
 
 
 
 
23.5 
 
C
O
H
HH
1 091 09. .
1 5.
 
 
 
 
26.3 
C Cl
C
C  
 
10.39 
 
Car O Cal
1 37.1 5.
 
 
2.67 
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The molar refraction of a pure liquid (MRD)1 were calculated by the 
following equation: 
( ) 221 11
n MMRD
n ρ
⎡ ⎤−= ⎢ ⎥+⎣ ⎦
                        … (3.2.3) 
where n, M and ρ are refractive index, molecular weight and density of pure 
liquid respectively. 
 For solutions, the eq. (3.2.4) was used to determine molar refraction. 
               ( ) 212 1 1 2 2212
12 12
1
1
n X M X MMRD
n ρ
⎡ ⎤ ⎡ ⎤− += ⎢ ⎥ ⎢ ⎥+⎣ ⎦ ⎣ ⎦
            … (3.2.4)     
 where n12 and ρ12 are refractive index and density of solution respectively. X1 
and X2 are the mole fractions and M1 and M2 are the molecular weight of the 
solvent and solute respectively.   
 The plots of (MRD)12 verses concentration for Chalcones series in DMF 
and Chloroform are given in Figures 3.2.2 and 3.2.3. It is evident from these 
figures that (MRD)12 increase with the increase in concentration. The molar 
refraction of solid compounds was determined by the equation: 
                ( ) ( ) ( )1 212 1 2MRD X MRD X MRD= +             … (3.2.5)                       
 Using these (MRD)2 and  density (ρ2) values, the refractive indexes of 
all the compounds were calculated from eq. (3.2.3). The molar refraction 
(MRD)2 and refractive index of all the compounds are reported in Table 3.2.4. 
 It is evident from Table 3.2.4 that both (MRD)2 and refractive index of 
compounds are different in each solvent. This again proves that in different 
solvents, intermolecular interactions are different, which affect these 
parameters.  
 Further, for different compounds (MRD)2  are quite different whereas 
refractive index differ only slightly. This suggest that although substitution 
affect (MRD)2 largely, refractive index only slightly. However, the variation of 
refractive index of all the compounds in a particular solvent is very less. 
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Figure 3.2.2: The plots of molar refraction (MRD)12 against concentration    
of chalcones in DMF solutions at 303.15 K. 
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Figure 3.2.3: The plots of molar refraction (MRD)12 against concentration 
of chalcones in chloroform solutions at 303.15 K. 
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Table 3.2.4: Molar refraction (MRD)2 and refractive index (n) of 0.1M   
solution of chalcones in DMF and chloroform at 303.15 K. 
Compounds 
Solvents 
DMF Chloroform 
(MRD)2 n (MRD)2 n 
NVA-1 89.1602 1.4325 113.69 1.4475 
NVA-2 120.4816 1.4356 91.41 1.4429 
NVA-3 100.6912 1.4238 123.88 1.4510 
NVA -4 90.4335 1.4219 135.60 1.4531 
NVA -5 111.7483 1.4245 98.38 1.4450 
NVA -6 115.5976 1.4243 165.30 1.4470 
NVA -7 84.0269 1.4208 134.06 1.4504 
NVA -8 103.1638 1.4248 119.41 1.4486 
NVA -9 107.2662 1.4249 112.98 1.4489 
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     INTRODUCTION 
Conductivity is the ability of a material to conduct electric current. The 
conductance of such electrolytic solutions depends on the concentration of 
the ions and also on the nature of the ions present (i.e., their charges and 
mobilities).Thus the conductance behavior as a function of concentration has 
been different for strong and weak electrolytes. Conductivity, the inverse of 
resistivity is determined from the voltage and current values according to 
Ohm's law 1.  
Conductivity measurement has widespread use in industrial 
applications that involve the detection of contaminants in water and 
concentration measurements 2. 
Literature survey shows that conductance of many inorganic and 
organic compounds have been measured in aqueous and non-aqueous 
solvents3-14.  It is also used to determine the  dissociation   constant and 
limiting equivalent conductance of weak electrolytes15, electro osmotic flow16, 
for studying conformational changes in polyelectrolytes in aqueous solutions17 
etc. 
Further, conductometry method is useful to various biological 
processes 18-21, to determine ascorbic acid in vitamin C tablet 22, carbon in 
uranium carbide and its solution in nitric acid 23, enzymatic degradation of 
microbial biofilm 24, dye-surfactant ion pair formation in aqueous solutions 25 
etc. Morita et al reported ionic conductance of polymeric electrolytes and of 
polymeric composite solid electrolytes 26. The antibiotic residues in bovin 
kidneys have also been detected by conductometry 27. 
Thus, in the present section conductance of all the synthesized 
Chalcones was measured in DMF and Chloroform solutions at 303.15 K, over 
a wide range of concentration.   
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    EXPERIMENTAL 
The solvents DMF and Chloroform were purified by fractionally 
distillation by the method reported in the literature 
28
.  
The solutions of different concentrations were prepared for each 
compound in DMF and Chloroform and the conductance of each solution was 
measured by using Equip-tronics Conductivity Meter (Model No. 664) having 
cell constant 0.86 cm-1 at 303.15 K. The measured conductance was 
corrected by subtracting the conductance of pure solvent. 
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   RESULTS AND DISCUSSION 
 The measured conductance (k) of each solution after correction was 
used to determine the specific conductance (κ), which is then used for the 
calculation of equivalent conductance (λc).  
The equations used for calculating specific conductance (κ ) and 
equivalent conductance (λc) are: 
                                             kκ θ=      … (3.3.1) 
                                     1000c C
κλ =                … (3.3.2) 
where θ is the cell constant (= 0.86) and c is the concentration (g.equi./lit.) of 
solution. 
 Tables 3.3.1 and 3.3.2 show the equivalent conductance of all the 
studied compounds in DMF and Chloroform solutions at 303.15 K along with 
measured conductance (k). The variation of conductance with concentration 
for these compounds in both the solvents is given in Figures 3.3.1 and 3.3.2. 
For studied compounds, conductivities are observed to be less in chloroform 
than those in DMF. Further, for all the studied systems, conductance 
increases with concentration. Up to 0.01 g.equi./lit. Conductance increases 
linearly with concentration. However, for most of the compounds at higher 
concentration, non-linearly increase is observed.   
The equivalent conductance (λc) is plotted against √C for all studied 
compounds and is shown in Figures 3.3.3 and 3.3.4. In both DMF and 
Chloroform solutions, usually λc increases with dilution. But for certain 
compounds in both the DMF (NVA-9), and Chloroform (NVA-2) solutions, λc 
do not increase continuously but bend downward at low concentrations. This 
typical behavior may be due to interactions within the molecule thereby 
causing constriction within the molecule or due to association between solute 
with solvent molecules. Further, It is evident from these figures that most of 
the compounds behave as weak electrolytes whereas some of them exhibited 
slightly strong electrolytic behavior. Further, the behavior is different in 
different solvents.  
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So, for few compounds, λ0 values were evaluated by extrapolation. 
These values are compared with those determined by an alternate procedure 
using the following equation: 
                                     ( )0 0 ck k c cλ φ= + +                                                  ….. (3.3.3) 
where k and k0 are the electrolytic conductivity of the solutions and solvent 
respectively. c is the equivalent concentration and the function Φ(c) denotes 
the effect of interionic interactions. The limiting conductivity can be 
determined accurately from the slope, dk/dc of plot of k verses c, provided 
other derivatives (dk0/dc) and d[cΦ(c)]/dc in differential form of equation (3.3.3) 
are neglected as compared to λ0, which can be determined from differential 
form of equation (3.3.3) is  
                                       ( )0 0
cd cdkdk
dc dc dc
φλ
⎡ ⎤⎣ ⎦= + +              ….. (3.3.4) 
Table 3.3.3 shows the λ0 values for all studied compounds along with 
those determined by extrapolation. For the system where λc decreases at low 
concentrations, λ0 could not be evaluated. Comparison of λ0 values in Table 
3.3.3 show that for most of the systems, values are in good agreement. 
However, for some cases, deviations are significant suggesting thereby that 
equations (3.3.3) and (3.3.4) are not valid for these systems. This is because 
of the fact in these equations, interionic interactions are neglected which are 
actually present in the studied solutions.  
Table3.3.3 shows that only for some compounds, λ0 could not be 
evaluated by extrapolation of plots λc against √C (Figures 3.3.3 and 3.3.4). 
these values are much different than those calculated from eq. 3.3.4. The 
reason may be due to the fact that in calculating λ0 by equation 3.3.4, the 
terms for interionic interaction are ignored. As interaction exist in the studied 
systems, this lead to series error as observed by large deviations in Table 
3.3.3.
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Table 3.3.1: The Conductance (k) and equivalent conductance (λC) of Chalcones in DMF at 303.15 K. 
Conc. 
(gm/lit) 
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.)
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.)
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.)
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.)
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.)
  NVA-1  NVA-2  NVA-3  NVA-4  NVA-5 
0 2.35 --- 2.35 --- 2.35 --- 2.35 --- 2.35 --- 
0.001 6.38 34.6580 5.11 24.6820 3.52 10.0620 2.79 3.7840 3.02 5.7620 
0.002 6.50 17.8450 5.86 15.5660 3.72 5.8910 3.10 3.2250 3.58 5.2890 
0.004 6.66 9.2751 7.25 10.7715 4.12 3.8055 4.27 4.1280 4.24 4.0635 
0.006 6.76 6.3210 8.34 8.7433 4.51 3.0960 5.19 4.0707 4.82 3.5403 
0.008 6.93 4.9235 9.12 7.3960 4.92 2.7628 6.27 4.2140 5.23 3.0960 
0.01 7.09 4.0764 10.10 6.7596 5.52 2.7262 7.57 4.4892 5.75 2.9240 
0.02 8.64 2.7047 11.98 4.1882 6.98 1.9909 9.69 3.1562 8.03 2.4424 
0.04 11.22 1.9071 14.03 2.5349 8.35 1.2900 12.38 2.1565 11.27 1.9178 
0.06 13.57 1.6082 15.73 1.9336 9.99 1.0951 14.26 1.7071 13.91 1.6569 
0.08 15.67 1.4319 17.27 1.6157 11.54 0.9879 16.07 1.4749 16.21 1.4900 
0.1 18.07 1.3519 18.32 1.3829 13.34 0.9451 17.18 1.2754 18.31 1.3726 
  NVA-6  NVA-7  NVA-8  NVA-9   
0.001 3.73 11.8680 2.78 3.6980 3.15 6.8800 2.61 2.2360   
0.002 4.22 8.0410 3.00 2.7950 3.46 4.7730 2.92 2.4510   
0.004 4.93 5.5470 3.54 2.5585 4.25 4.0850 3.78 3.0745   
0.006 5.99 5.2173 4.10 2.5083 5.43 4.4147 4.75 3.4400   
0.008 6.88 4.8698 4.71 2.5370 6.86 4.8483 5.84 3.7518   
0.01 8.04 4.8934 5.57 2.7692 8.14 4.9794 7.34 4.2914   
0.02 10.11 3.3368 7.80 2.3435 11.24 3.8227 9.69 3.1562   
0.04 12.59 2.2016 9.37 1.5093 13.26 2.3457 11.55 1.9780   
0.06 14.76 1.7788 10.38 1.1510 15.34 1.8619 13.27 1.5652   
0.08 16.87 1.5609 11.79 1.0148 17.07 1.5824 14.55 1.3115   
0.1 18.27 1.3691 13.57 0.9649 18.65 1.4018 15.62 1.1412   
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Table 3.3.2: The Conductance (k) and equivalent conductance (λC) of Chalcones in Chloroform at 303.15 K. 
Conc. 
(gm/lit) 
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.) 
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.)
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.)
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.)
κ.105
(Ω) 
ૃC 
(cm2/Ω.equiv.) 
  NVA-1  NVA-2  NVA-3  NVA-4  NVA-5 
0 0.120 --- 0.120 --- 0.120 --- 0.120 --- 0.120 --- 
0.001 0.140 0.1720 0.130 0.0860 0.320 1.7200 0.240 1.0320 0.270 1.2900 
0.002 0.150 0.1290 0.140 0.0860 0.330 0.9030 0.250 0.5590 0.280 0.6880 
0.004 0.180 0.1290 0.170 0.1075 0.360 0.5160 0.280 0.3440 0.310 0.4085 
0.006 0.210 0.1290 0.200 0.1147 0.390 0.3870 0.310 0.2723 0.340 0.3153 
0.008 0.240 0.1290 0.230 0.1183 0.420 0.3225 0.340 0.2365 0.370 0.2688 
0.01 0.260 0.1204 0.280 0.1376 0.472 0.3027 0.390 0.2322 0.420 0.2580 
0.02 0.310 0.0817 0.300 0.0774 0.490 0.1591 0.410 0.1247 0.440 0.1376 
0.04 0.330 0.0452 0.320 0.0430 0.510 0.0839 0.430 0.0667 0.460 0.0731 
0.06 0.370 0.0358 0.375 0.0366 0.550 0.0616 0.470 0.0502 0.547 0.0612 
0.08 0.410 0.0312 0.460 0.0366 0.590 0.0505 0.510 0.0419 0.675 0.0597 
0.1 0.470 0.0301 0.470 0.0301 0.640 0.0447 0.570 0.0387 0.761 0.0551 
  NVA-6  NVA-7  NVA-8  NVA-9   
0.001 0.440 2.7520 0.360 2.0640 0.382 2.2532 0.434 2.7004   
0.002 0.452 1.4276 0.520 1.7200 0.512 1.6856 0.611 2.1113   
0.004 0.480 0.7740 0.800 1.4620 0.660 1.1610 0.853 1.5760   
0.006 0.510 0.5590 1.080 1.3762 1.000 1.8920 1.312 1.7085   
0.008 0.540 0.4515 1.411 1.3878 1.112 1.0664 1.643 1.6372   
0.01 0.590 0.4042 1.790 1.4362 1.340 1.0492 1.900 1.5308   
0.02 0.610 0.2107 2.750 1.1309 2.040 0.8256 3.150 1.3029   
0.04 0.630 0.1097 3.710 0.7719 2.950 0.6085 4.340 0.9073   
0.06 0.670 0.0788 4.890 0.6837 3.200 0.4415 5.040 0.7052   
0.08 0.710 0.0634 6.250 0.6590 4.320 0.4515 5.690 0.5988   
0.1 0.760 0.0550 7.280 0.6158 4.450 0.3724 5.830 0.4911   
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Figure 3.3.1: The variation of conductance with concentration for 
chalcones in DMF at 303.15 K. 
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Figure 3.3.2: The variation of conductance with concentration for 
chalcones in chloroform at 303.15 K. 
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Figure 3.3.3: The variation of equivalent conductance with √C for 
chalcones in DMF at 303.15 K. 
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Figure 3.3.4: The variation of equivalent conductance with √C for 
chalcones in chloroform at 303.15 K. 
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Table 3.3.3; The limiting equivalent conductance (λ0) of all the 
compounds in DMF and Chloroform at 303.15 K. 
Compound 
Code 
λ0 
mho.cm2.equi.-1 
from graph 
λ0103 
mho.cm2.equi.-1 
from eq. (3.3.4) 
λ0 
mho.cm2.equi.-1 
from graph 
λ0103 
mho.cm2.equi.-1 
from eq. (3.3.4) 
DMF Chloroform 
NVA -1 -- 2.86 0.161 0.161 
NVA -2 -- 6.77 -- 0.156 
NVA -3 1.94 2.64 -- 0.258 
NVA -4 -- 5.18 -- 0.214 
NVA -5 7.12 3.23 -- 0.230 
NVA -6 -- 5.16 -- 0.032 
NVA -7 4.91 3.05 2.88 0.160 
NVA -8 -- 5.61 -- 0.113 
NVA -9 -- 4.92 -- 0.175 
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    INTRODUCTION 
The maximum amount of a substance that can dissolve in fixed 
quantity of solvent at given temperature and pressure is called the solubility of 
the substance.  
The solubility data has been of fundamental importance in a large 
number of scientific disciplines and practical applications such as in drug 
discovery, drug formulation, transport of pollutants 1-4, crystallization-based 
separation investigations etc. 
 Literature survey shows that a number of workers have studied 
solubility of various compounds in various solvents 5-11. Domanska has 
studied the solubility of n-paraffin hydrocarbons in binary solvents 12. Ma and 
Xia have reported the solubility of aromatic acids in various solvents 13. The 
solubilization behavior of a poorly soluble drug has also been studied in 
presence of surfactants and cosolvents 14. The solubility of cinnamic acid 
esters have also been studied in ionic liquids 15. Further, many researchers 
have been worked on solubility of some fatty acid 16, ionic liquids 17, inorganic 
salt 18-22, some trace elements 23-25,protein 26-27, drugs 28etc. 
 When a solute is dissolved in a solvent, heat is either absorbed or 
evolved. Thus, dissolution of a solute in a solvent is accompanied by the heat 
change i.e., enthalpy change (∆H) of the system. If the heat is absorbed i.e., 
the solution is cooler then ∆H is positive. If the heat is evolved i.e., the 
solution is warmer then ∆H is negative. The heat of solution is defined as the 
change in enthalpy when one mole of substance is dissolved in specified 
quantity of solvent at a given temperature. 
 The molar heat of solution is one of the most basic of thermodynamic 
properties and it has been useful for the advancement of theoretical 
developments through an understanding of the intermolecular forces-solution 
structure-property relationship 29.  
 The molar heat of solution and melting temperature of a substance can 
be determined from the solubility measurements at different temperatures 30. 
Using solubility data, various workers have reported various thermodynamic 
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parameters such as enthalpy, Gibb’s energy and entropy of different 
substances in different pure and mixed solvents 31-37.  
In the present work, the solubility for some chalcones was determined 
in chloroform and dichloromethane at different temperatures (293.15 to 
313.15) K. Further, some thermodynamic parameters such as enthalpy, 
Gibb’s energy and entropy of different solutions have also been evaluated 
from the solubility data. 
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     EXPERIMENTAL 
           The solubility of Chalcones has been studied in chloroform and 
dichloromethane (MDC). These solvents were purified by the method reported 
in the literature 38.  
 The solubilities were measured by a gravimetric method 39. For each 
measurement, an excess mass of chalcone was added to a known mass of 
solvent. Then, the equilibrium cell was heated to a constant temperature with 
continuous stirring. After, at least 3 h (the temperature of the water bath 
approached constant value, then the actual value of the temperature was 
recorded), the stirring was stopped and the solution was kept still for 2 h. A 
portion of this solution was filtered and by a preheated injector, 2 ml of this 
clear solution was taken in another weighted measuring vial (m0). The vial 
was quickly and tightly closed and weighted (m1) to determine the mass of the 
sample (m1- m0). Then, the vial was covered with a piece of filter paper to 
prevent dust contamination. Then, the vial was placed in at room temperature 
to evaporate the solvent. After the solvent in the vial had completely 
evaporated, the vial was dried and reweighed (m2) to determine the mass of 
the constant residue solid (m2- m0). All the weights were taken using an 
electronic balance (Mettler Toledo AB204-S, Switzerland) with an accuracy of 
± 0.0001 g. Thus, the solid concentration of the sample solution of mole 
fraction, x, was then determined from the following equation:  
                 2 0 1
2 0 1 1 2 2
( ) /
( ) / ( ) /
m m Mx
m m M m m M
−= − + −       .. (3.4.1) 
where M1 is the molar mass of chalcones and M2 is the molar mass of the 
solvent. 
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   RESULTS AND DISCUSSION 
The mole fraction solubility (x) of synthesized compounds in the 
studied solvents is given in Table 3.4.1. It is evident from the Table that the 
solubility increases with temperature in both the solvents. Figure 3.4.1 shows 
the variation of mole fraction solubility (x) against temperature for NVA-1 in 
chloroform and MDC.  
It is observed that almost for all the compounds, solubility values 
linearly with temperature. Further, overall solubility of studied compounds is 
greater in MDC than that in chloroform.  
The temperature dependence solubility in solvents is described by the 
modified Apelblat equation 40,41    
                            ….. (3.4.2) 
where x is the mass fraction solubility of compounds; T is the absolute 
temperature and A, and B are the coefficients. The values of these 
coefficients are given in Table 3.4.2. Using these values of A and B, 
calculated solubilities xc were evaluated and are reported in Table 3.4.1. 
The relative deviations (RD) between the experimental and calculated 
values of solubilities are also calculated by equation 3.4.3 and are given in 
Table 3.4.1.  
   Relative Deviation  ⎛ ⎞⎜ ⎟⎝ ⎠
cx - x=
x
           ….. (3.4.3) 
Further, relative average deviations (ARD) and root-mean-square 
deviations (rmsd) were calculated by equations 3.4.4 and 3.4.5 and are listed 
in Table 3.4.2. 
   
N
i c
i i
x x
x
⎛ ⎞−⎜ ⎟⎝ ⎠∑
1ARD =
N
                              ….. (3.4.4)  
    
1/ 22
1
( )
1
N
ci i
i
x xrmsd
N=
⎡ ⎤−= ⎢ ⎥−⎣ ⎦∑             ….. (3.4.5) 
where N is the number of experimental points. 
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  Table 3.4.1: The experimental solubility (x), calculated solubility 
 (xc) and relative deviation (RD) of NVA series in Chloroform and 
 Dichloromethane at different temperatures. 
 Chloroform Dichloromethane 
Temp. 
K x. 10
3 xc.103 100 RD x. 103 xc.103 100 RD 
 NVA-1 NVA-1 
293.15 5.6660 5.1774 8.6230 8.9330 10.0937 -12.9851 
298.15 6.5141 5.8374 10.3866 14.6171 13.2873 9.1010 
303.15 7.3912 6.5815 10.9554 19.5442 17.4921 10.5013 
308.15 8.2940 7.4204 10.5327 23.8635 23.0272 3.5010 
313.15 9.2345 8.3663 9.4014 27.6761 30.3153 -9.5339 
 NVA-2 NVA-2 
293.15 0.8125 0.7866 3.1948 3.5648 3.4788 2.4138 
298.15 0.8699 0.8394 3.5077 6.1866 4.8386 21.7894 
303.15 0.9286 0.8958 3.5378 8.7791 6.7299 23.3417 
308.15 0.9936 0.9559 3.7940 11.350 9.3605 17.5256 
313.15 1.0552 1.0201 3.3239 13.8922 13.019 6.2788 
 NVA-3 NVA-3 
293.15 3.7360 3.1901 14.6139 1.0250 1.2626 -23.1777 
298.15 4.0605 3.4730 14.4687 2.3081 1.9398 15.9599 
303.15 4.3825 3.7811 13.7226 3.5770 2.9802 16.6842 
308.15 4.7020 4.1165 12.4531 4.8318 4.5787 5.2377 
313.15 5.0191 4.4816 10.7085 6.0726 7.0345 -15.8408 
 NVA-4 NVA-4 
293.15 0.3365 0.5229 -55.4173 20.7421 23.3183 -12.4199 
298.15 1.6490 1.0066 38.9531 26.7072 27.3631 -2.4564 
303.15 2.9570 1.9377 34.4688 31.8882 32.1105 -0.6956 
308.15 4.2650 3.7300 12.5439 38.8004 37.6811 2.8859 
313.15 5.5685 7.1799 -28.9394 44.9301 44.2171 1.5863 
 NVA-5 NVA-5 
293.15 6.2033 6.7354 -8.5778 0.7198 0.8754 -21.4893 
298.15 6.6599 7.1340 -7.1192 1.4667 1.2860 12.2833 
303.15 7.1025 7.5561 -6.3874 2.1875 1.8924 13.4899 
308.15 7.5415 8.0033 -6.1236 2.8768 2.7837 3.2358 
313.15 7.9670 8.4769 -6.3993 3.5398 4.0948 -15.6789 
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 Chloroform Dichloromethane 
Temp. 
K x. 10
3 xc.103 100 RD x. 103 xc.103 100 RD 
 NVA-6 NVA-6 
293.15 6.0741 6.6551 -9.5654 3.3644 3.916 -16.4136 
298.15 9.7428 9.1095 6.5002 5.9615 5.4968 7.7959 
303.15 13.5748 12.4692 8.1441 8.5123 7.7145 9.3724 
308.15 17.5713 17.0681 2.8640 11.012 10.827 1.6766 
313.15 21.7481 23.3630 -7.4255 13.467 15.195 -12.8318 
 NVA-7 NVA-7 
293.15 6.5624 5.1287 21.8470 2.0630 1.7280 16.2401 
298.15 7.4556 5.6964 23.5957 2.9055 2.1856 24.7747 
303.15 8.3636 6.3269 24.3510 3.7936 2.7645 27.1277 
308.15 9.2687 7.0273 24.1828 4.1240 3.4967 15.2110 
313.15 10.180 7.8051 23.3281 5.7231 4.4228 22.7194 
 NVA-8 NVA-8 
293.15 9.9591 8.6000 13.6468 4.5115 3.6677 18.7033 
298.15 10.0359 8.6431 13.8781 5.4687 4.3040 21.2977 
303.15 10.1120 8.6864 14.0980 6.4837 5.0506 22.1028 
308.15 10.1880 8.7299 14.3110 7.5618 5.9268 21.6221 
313.15 10.2632 8.7737 14.5131 8.7093 6.9549 20.1434 
 NVA-9 NVA-9 
293.15 16.321 15.020 7.9679 9.2359 8.5974 6.9128 
298.15 15.899 15.478 2.6482 11.891 10.448 12.1311 
303.15 16.417 15.949 2.8497 14.639 12.697 13.2637 
308.15 16.924 16.435 2.8911 17.500 15.431 11.8256 
313.15 18.458 16.935 8.2489 20.380 18.752 7.9841 
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Table 3.4.2: Coefficient A and B of equation 3.4.1, Relative Average  Deviation 
(ARD), and root Mean Square Deviation (rmsd) of NVA series in 
Chloroform and Dichloromethane. 
 
Compounds A B 107 rmsd 100 ARD 
Chloroform 
NVA-1 -12.300 0.024 1.4345 9.9798 
NVA-2 -10.960 0.013 0.0026 3.4716 
NVA-3 -10.732 0.017 0.8183 13.1933 
NVA-4 -45.960 0.131 2.1847 0.3218 
NVA-5 -8.373 0.012 0.5934 -6.9214 
NVA-6 -23.423 0.063 2.4110 0.1034 
NVA-7 -11.430 0.021 9.9808 23.4609 
NVA-8 -5.050 0.001 5.0819 14.0894 
NVA-9 -5.958 0.006 2.3224 4.9211 
Dichloromethane 
NVA-1 -20.72 0.055 7.4939 0.1168 
NVA-2 -25.01 0.066 5.3705 14.2698 
NVA-3 -31.85 0.085 0.7688 -0.2273 
NVA-4 -13.14 0.032 4.4389 -2.2199 
NVA-5 -29.67 0.077 0.2300 -1.6318 
NVA-6 -25.41 0.067 2.0889 -2.0800 
NVA-7 -20.14 0.047 1.8868 21.2145 
NVA-8 -14.99 0.032 4.9366 20.7738 
NVA-9 -16.19 0.039 6.5944 10.4234 
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 Using these solubility data, some thermodynamic parameters such as 
enthalpy, entropy and Gibbs energy of dissolution have also been evaluated. 
 According to van’t Hoff analysis42, the standard enthalpy change of 
solution is obtained from the slope the ln x versus 1/T plot.  
   ln x = [∆Hsol (T-Tm)]/RT.Tm                              ….. (3.4.6) 
where T is temperature and Tm is the melting temperature of the studied 
compounds. 
 However, in recent thermodynamic treatments, some modifications 
have been introduced in the van’t Hoff equation to diminish the propagation of 
errors and consequently to separate the chemical effects from those due to 
statistical treatment used when enthalpy-entropy compensation plots are 
developed 43. For this reason, the mean harmonic temperature (Thm) is used 
in the van’t Hoff analysis, which is calculated by the following equation. 
                      ( )1hm n
i
nT
T
=
∑
                                          ….. (3.4.7) 
where n is the number of temperatures studied and T is absolute temperature 
of the experiment. In the present case, the Thm value obtained is 303.15 K. 
So, the modified van’t Hoff equation is 44-45. 
   ln
1 1
sol
hm P
Hx
R
T T
Δ∂ = −⎛ ⎞∂ −⎜ ⎟⎝ ⎠
                                ….. (3.4.8) 
where ∆Hsol is the heat of solution and R is the gas constant.  
 Figure 3.4.2 shows the van’t Hoff plots for NVA-1 in chloroform and 
dichloromethane solutions. From the slope of these linear plots, the values of 
∆Hsol were evaluated. Whereas Gibb’s energy of dissolution (∆Gsol) were 
evaluated from the intercept using the following equation.45 
∆Gsol = -RThm. intercept                          ….. (3.4.9) 
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Figure 3.4.1: The mole fraction solubility (x) against temperature (T/K) for 
NVA-1 in Chloroform (A) and Dichloromethane (B). 
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Figure 3.4.2: van’t Hoff plots for for NVA-1 in [A] Chloroform and [B] MDC. 
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Table 3.4.3: The thermodynamic parameters of Chalcones in Chloroform 
and MDC at 302.99 K (Thm). 
Compound 
code 
∆Hsol ∆Gsol ∆Ssol ∆Hsol ∆Gsol ∆Ssol 
kJ.mol-1 kJ.mol-1 J.mol
-
1.K-1 kJ.mol
-1 kJ.mol-
1 
J.mol-
1.K-1 
 Chloroform Dichloromethane 
NVA-1 0.0019 12.3893 -40.8846 0.0042 10.1776 -33.5771 
NVA-2 19.1887 19.5098 -1.0597 50.9731 12.1971 127.9801
NVA-3 12.9948 14.0360 -3.4364 65.9051 14.6204 169.2648
NVA-4 100.8821 15.5675 281.5801 24.9370 8.7914 53.2886 
NVA-5 9.5362 12.4742 -9.6969 59.1791 12.2903 154.7561
NVA-6 48.0799 11.0333 122.2719 51.9043 12.2903 130.7458
NVA-7 16.7361 12.0787 15.3717 36.5400 14.2324 73.6260 
NVA-8 1.1473 11.5724 -34.4078 25.0501 12.7336 40.6504 
NVA-9 5.1522 10.2801 -16.9247 29.8888 10.7260 63.2469 
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Using these evaluated ∆Hsol and ΔGsol values, the entropies of 
solutions ΔS were obtained from the following equation 46  
   Δ ΔΔ sol solsol
hm
H - GS =
T
                              ….. (3.4.10) 
It is evident from Table 3.4.3 that for all the compounds ∆Hsol and ΔGsol values 
are positive whereas ∆Ssol values are both negative and positive for both the 
solvents.  When stronger bonds are broken and weaker bonds are formed, 
energy is consumed and so ∆Hsol becomes positive 46. This indicates 
endothermic dissolution of compounds where the enthalpy term contributes to 
an unfavorable positive value of ΔGsol  46. 
 Thus, the positive values of ΔG indicates that the dissolution process is 
not spontaneous. 46,47 whereas negative entropy suggests more ordered 
structure in solutions 46. 
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INTRODUCTION 
The partition coefficient or distribution coefficient is the ratio of 
concentrations of a substance in the two phases of a mixture of two 
immiscible solvents at equilibrium.1 These coefficients have been a measure 
of differential solubility of the substance between two solvents. The partition 
coefficient is of great importance in various fields such as industry, pharmacy, 
medicine, chemistry etc. 
Partition coefficient is very useful in cosmetic formulations, since it is a 
measure of the ability of a material to penetrate the hair and skin. Partition 
coefficients have been also used in the liquid-liquid chromatographic 
separations 2. 
 In pharmacokinetics, the distribution coefficient has a strong influence 
on ADME properties (Absorption, Distribution, Metabolism, and Excretion) of 
the drug 3. Whereas in Pharmacodynamics, the hydrophobic effect is the 
major driving force for the binding of drugs to their receptor targets 4-5. 
Moldovan et al. have suggested several physicochemical properties of 
drug molecules, one of them is partition coefficient, which is used to 
characterize the lipophilicity of drugs 6-7. 
Lipophilicity of drug molecules plays an important role in their 
absorption, permeation, and disposition by affecting the drug’s ability to be 
absorbed through the gut wall and to cross the blood/brain barrier 8. 
The distribution between water and an immiscible nonpolar solvent is 
acknowledged as a useful descriptor for the hydrophobicity of a substance. n-
Octanol and water are widely accepted as the best two-phase system to 
model the partitioning between biomass and water. Relationships between the 
partition coefficient of this system and bioconcentration, 9-12 soil sorption, 13-15 
and toxicity 16-18 for fish have also been found. 
 The common lipophilicity scale of molecules is defined by the 
octanol/water partition coefficient; log P, which is a measure of the drug’s 
preference for an organic compound for water versus a less polar organic 
solvent  19. 
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Partition coefficients indicate drug transport characteristics – the ability 
of drugs to reach the site of action from the site of application. Drugs are 
distributed by the blood and must penetrate and traverse many cells to reach 
the site of action. Hence, the partition coefficient indicates which tissues a 
given compound can reach 20-21. The partition coefficient of a solute between 
octanol and water has been widely used to predict drug pharmacokinetic 
properties 22-24. 
The partition coefficient or log P has been known to be one of the most 
important quantitative parameters that correlate with the variation in biological 
activities. In QSAR studies, log P is the most widely used hydrophobic 
parameter. Liu et al have measured lipophilicity by reverse–phase high 
performance liquid chromatography.25-26 The partition coefficient between 
octanol-water phases of some organic compounds have also been studied by 
some workers 27-29. Gasslander et al. have determined polymer-water partition 
coefficient by using organic modifiers in the aqueous phase 30. Ming et al. 
have reported that octanol-water partition coefficient of monobasic acidic 
compounds 31. 
In the present study, partition coefficients of synthesized chalcones 
have been studied in n-Octanol-water system by UV spectroscopy at different 
pH. 
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EXPERIMENTAL 
n-Octanol is of analytical grade. The purity of solvent was checked by 
GC and found to be 99.9%. Distilled water was used throughout for all 
experiments. 
Preparation of standard solution:- 
 10 mg sample was dissolved in n-Octanol to give 100 ml solution of 
100 ppm. This solution was known as standard solution. λmax values were 
measured using UV spectrophotometer (Shimadzu, UV-1700, Pharmaspec) 
from this solution. Suitable dilutions were made from this standard solution (8 
μg to 20 μg) and absorbance (OD) was measured. The plot of OD verses 
concentration gives the calibration curve.  
Determination of Partition coefficient:- 
 A known amount of the compound under investigation was dissolved in 
n-Octanol at a concentration not higher than 20 μg. Equal volumes of this 
solution and water is mixed in oven dried stoppered flask and the mixture was 
stirred for 24 hrs. at room temperature. After 24 hrs., the solution was 
transferred into 250 ml of separating funnel and allow to stand to separate the 
aqueous and organic layers. The organic layer will be upper one while lower 
will be aqueous. The organic layer was then analyzed by UV 
spectrophotometer. Using calibration curve, the concentration of compounds 
in organic layer was then evaluated. 
As, partition coefficient is highly influenced by pH, a wide range of pH 
(0.84 to 8.0) is selected. For 0.84 pH, 0.1 N HCl was taken whereas for 6.0, 
7.4 and 8.0, phosphate buffer was used.  
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THEORY 
Partition coefficient (P) is defined as the ratio of the compounds in 
organic phase to that present in the aqueous phase. i.e., 32 
    org
aq
C
P
C
=                  …(3.5.1) 
where Corg and Caq are concentration of solute in organic and aqueous phases 
respectively. 
 In the present case, concentrations were determined by UV 
measurement so, equation (3.5.1) written as: 33 
     E
E E
BP
B A
= −     …(3.5.2) 
where, BE=Absorbance before separation and AE=Absorbance after 
separation. From equation (3.5.2), log P were calculated for each set of 
experiment. 
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RESULTS AND DISCUSSION 
The values of log P for the studied compounds at different pH are 
given in Table 3.5.1 and Figure 3.5.1. The log P values depend upon the 
hydrophilic and hydrophobic character of compounds. These values are 
higher for compounds having hydrophobic nature whereas lower log P is for 
compounds of hydrophilic type.  
Table 3.5.1 shows that log P depends on pH of solution. The selected 
pH values for the present study were due to their existence in human body. 
As HCl exists in gastric juice in stomach, 0.1 N HCl is taken. Blood has 7.4 
pH, so the study is done at pH 7.4. Further, the middle and upper range of 
body pH is 6.0 and 8.0 respectively, so study was done at this pH also. 
In water, log P is maximum for NVA-07 suggesting thereby 
hydrophobic nature of this compounds whereas NVA-01 is highly hydrophilic 
as it’s log P value is minimum. NVA-07 contains -4-OH-C6H4 side chain 
whereas NVA-01 contains -4-Cl-C6H4 side chain. Thus, the presence of -4-
OH-C6H4 side chain (in NVA-07) causes hydrophobic nature in neutral pH.  
However, the hydrophilic or hydrophobic nature of studied compounds 
varies with pH. In 0.1N-HCl, again NVA-07 is highly hydrophobic whereas 
NVA-05 containing 4-OCH3-C6H4 group is found to be hydrophilic. Thus, in 
gastric juice, NVA-07 will not be absorbed whereas NVA-05 can be easily 
absorbed. 
At 6.0 pH, log P is maximum in NVA-06 exhibiting maximum 
hydrophobicity whereas NVA-7 becomes most hydrophilic. Thus, at 6.0 pH, 
NVA-07 containing -4-OH-C6H4 substituent become hydrophilic whereas NVA-
06 containing 4-Br-C6H4 exibited hydrophobic nature. Thus, the result 
suggests that NVA-07 can be easily absorbed by the blood. Overall the order 
of hydrophobicity of compounds is: 
NVA-06 > NVA-08 > NVA-03 > NVA-04 > NVA-09 > NVA-05 > NVA-01 > 
NVA-02 > NVA-07.  
 In 7.4 pH range, among all these compounds NVA-02 containing 4-
NO2-C6H4 has minimum log P whereas maximum is observed for NVA-05  
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Table : 3. 5.1. log P values of chalcones 
 
Compounds 
Code 
Max absorption
Wavelength/nm
log P 
Water 0.1N HCl 
6.0 
pH 
7.4 
pH 
8.0 
pH 
NVA-01 371 0.724 0.883 0.876 1.767 1.681 
NVA -02 358 0.785 1.164 0.798 0.860 0.755 
NVA -03 359 1.647 1.113 1.511 1.972 1.370 
NVA -04 382 0.923 2.092 1.439 1.967 1.314 
NVA -05 383 1.621 0.626 1.267 2.011 1.906 
NVA -06 365 2.128 1.891 1.993 1.722 2.090 
NVA -07 360 2.768 2.370 0.068 1.893 2.592 
NVA -08 359 2.027 1.940 1.619 1.583 1.867 
NVA -09 365 1.537 1.003 1.401 1.861 1.259 
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   Figure: 3.5.1. log P for the studied compounds at different pH 
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which can be considered more hydrophobic in nature. Thus, NVA-05 containing 4-
OCH3-C6H4 group will not be absorbed in blood, and is less likely to spread in the 
body. However, it is more likely to accumulate in fatty tissues 34, 35.  The order of 
hydrophobicity of compounds is: 
NVA-05 > NVA-03 > NVA-04 > NVA-07 > NVA-09 > NVA-01 > NVA-06 > NVA-08 > 
NVA-02.  
However, at pH 8.0, log P values maximum for NVA-07 and minimum for 
NVA-02. Thus, at alkaline pH, NVA-07 will not be absorbed by the blood but can be 
accumulated in fatty tissues as observed by Rowe et al. 34 and Fresta et al. 35. The 
decreasing order of hydrophobicity of compounds is: 
NVA-07 > NVA-06 > NVA-05 > NVA-08 > NVA-01 > NVA-03 > NVA-04 > NVA-09 > 
NVA-02.  
 Thus, it is concluded that the studied compounds, NVA-07 shows hydrophobic 
characteristic in neutral, acidic, and alkaline systems, although it contains -4-OH-
C6H4  side chain. At 6.0 and 7.4 pH, hydrophobicity decreases. The reason for 
change in hydrophobic character at intermediate pH is not clear.  
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     INTRODUCTION 
The term dissociation constant is a specific type of equilibrium constant 
that measures the tendency of a larger molecule to separate (dissociate) 
reversibly into smaller components, as when a complex falls apart into its 
component molecules, or when a salt splits up into its component ions. The 
dissociation constant is usually denoted and is the inverse of the association 
constant. In the special case of salts, the dissociation constant can also be 
called an ionization constant or dissociation constant 1-4. 
There are many applications of dissociation constants. The nature of 
the functional groups can be determined by simple comparison of acidity or 
dissociation constant of the unknown compound with those of known 
compounds. The dissociation or formation constant also provide useful 
informations about tautomeric equilibria 5-6, solvent-solute interactions 7 etc. 
Now a day, various methods are available to determine dissociation 
constant. Roy  and Popelier have determined  acidic dissociation constant of 
substituted phenols in different solvent systems by the predictive QSPR 
models 8. Manallack have measured the acid-base dissociation constant of a 
drug 9 by measured for regulatory compliance. Hambor and Versteeg, have 
studied the dissociation constant and thermodynamic properties of various  
alkanolamines by measuring electromotive force 10-12. Casado et.al have 
determined acid dissociation constant of ester and lactones 13 by measured 
via kinetic study of its base-catalyzed hydrolysis. 
Spectrophotometric determination of the dissociation constant of 
different systems have been reported by various workers 14-17. Evagelou et al. 
(18) have reported the dissociation constants of the cephalosporin’s, cefepime 
and cefpirome by using UV spectrometry and pH potentiometry. Spectrometry 
is an ideal method when a substance is not soluble enough for potentiometry 
or when its pKa value is particularly low or high 19-22. 
Literature survey shows that many workers studied the dissociation 
constant of many complex substances 23-27 using different methods. The 
dissociation constants of various other acids in pure and mixed solvents have 
also been studied 28-33.  
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Further, in last few years dissociation constant of many substances 
have been studied such as carboxylic acid derivatives 34, vitamins 35, alcohols 
36, Gas hydrate 37-39, Some organic compounds 40 by various workers. 
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     EXPERIMENTAL 
The synthesized Chalcones of vanillin derivatives were recrystallized 
from DMF, which was of LR grade and was distilled by the reported method 
41.  
100 ppm solution of sample was prepared in DMF. This solution known 
as standard solution was used to determine λmax using UV spectrophotometer 
(SHIMADZU PHARMA SPEC-1700 UV VISIBLE) equipped with 1 cm path 
length cell, controlled by computer. The instrument was calibrated by usual 
procedure. 
The following set of mixtures were prepared. 
(1) 2 ml HNO3 (0.01 M) + 4 ml NaNO3 (0.01 M) + 19 ml DMF 
(2) 2 ml HNO3 (0.01 M) + 4 ml NaNO3 (0.01 M) + 2 ml ligand 
solution (15 ppm) + 17 ml DMF 
Thus, total volume of each set of solution was 25 ml and DMF:water ratio was 
90:10(v/v). 
To each set of solution, pH and absorbance (OD) were measured after 
each addition of 0.1 ml NaOH till there was no change in OD. 
A systronic pH meter (Model No. EQ 664) was used for the pH 
determination. pH meter was calibrated by known buffer solutions. The glass 
electrode and a saturated calomel electrode were used as indicator and 
reference electrodes respectively. 
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THEORY: 
 The protonation of a weak B can be represented as: 
BH+ B + H
+
 ….. (3.6.1) 
So, the equilibrium constant (K) can be given as:  
+
+
BH
BH
a .a
K =
a
 ….. (3.6.2) 
where a represents the activity of each species. The activity a is related to 
concentration c by the equation: 
a=c.γ ….. (3.6.3) 
where γ is the activity coefficient. 
Substituting the values of a in eq. (3.6.2) gives, 
[ ]
+H
K =a . B
BH
B
BH
γ
γ + +⎡ ⎤⎣ ⎦
 ….. (3.6.4) 
where square brackets  indicate the concentration of the species. 
Combining the activity coefficient with K yields the mixed conditional 
constant Ka (one that incorporates both activity and concentration) 42 gives: 
[ ]
+a H
K =a .
B
BH +⎡ ⎤⎣ ⎦
 ….. (3.6.5) 
Taking logarithm of above equation (3.6.5) gives: 
[ ]loga
BH
pK pH
B
+⎡ ⎤⎣ ⎦= +  ….. (3.6.6) 
Rearrangement of above equation gives: 
[ ]log aB pH pKBH + = −⎡ ⎤⎣ ⎦  ….. (3.6.7) 
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A plot of [ ]log B
BH +⎡ ⎤⎣ ⎦
 versus pH will therefore yield a straight line and pH=pKa 
when [ ]log B
BH +⎡ ⎤⎣ ⎦
=0, providing that the temperature and ionic strength are held 
constant 42. 
The concentrations of the individual species BH+ and B can be 
determined spectrophotometrically by measuring the absorbance (OD) at 
particular wavelength. However, if a series of solutions is prepared at various 
pH and the total concentration of compound ct = [BH+]+[B] is constant, it can 
be shown that the ratio of the conjugate forms is given by (42) 
0
0
a b
b a
C A A I
C A A
−= =−                   (Aa
0
 > Ab0) ….. (3.6.8 a) 
or 
0
0
a b
b a
C A A I
C A A
−= =−                 (Ab
0 > Aa0) ….. (3.6.8 b) 
where Ca and Cb represent [BH+] and [B] respectively. A, Aa0 and Ab0 
represent the measured absorbance, absorbance when [BH+]=ct and 
absorbance when [B] =ct respectively. A plot of absorbance, obtained on the 
series of solutions at a single wavelength, is plotted according to equation 
(3.6.7) to determine pKa.  
 However, for some weak bases, it is reported that if slope m 
of the plot (Fig.2) is not unity, pKa value should be calculated by the following 
equation 42: 
1/ 2.apK m H=  ….. (3.6.9) 
where H1/2 represents the pH at half protonation at log I=0. 
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 RESULTS AND DISCUSSIONS 
 Table 3.6.1 shows the experimental data of pH and OD for the studied 
compounds. The plot of OD versus pH is shown in Figure 3.6.1 for NVA-01. 
Using equation 3.6.8 (a or b), log I value were calculated and plotted against 
pH. The plot is a straight line and pKa value is evaluated at log I=0. This value 
of pKa is taken as half protonation (H1/2) by Ogretir et al. 43,44 
 Further, at each pH, from the absorbance data, pKa value was 
evaluated from equation (3.6.7) and average of pKa is reported in Table 3.6.2 
along with the value calculated from the graph. 
 In the studied compounds, the slope (m) of the plot (Figure 3.6.2) was 
also calculated. It is reported 43,44 that if m values are between 0.85 and 1.05 
then the bases are of Hammett type. In that case, m can be taken as unity. 
Thus, in the present study, m values are found to be between 0.60 and 0.96, 
so its observed that the studied compounds can be considered as other than 
of Hammett type. In that case m cannot always unity 45. And so H1/2 is equal 
to pKa, which is same as reported in Table 3.6.2.  
 Table 3.6.3 shows the compounds in their increasing order of acidity or 
basicity. It is observed that the -Br groups at para position of the phenyl ring 
makes NVA-06 the least acidic or most basic one, whereas NVA-07 is found 
to be most acidic due to the -OH group at para position. This is an agreement 
with the result of Berber and Ogretir who observed that the presence of OH 
group increases the acidic character of compounds.43,44   
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Table 3.6.1.  Experimental data of pH and Absorbance (OD) of chalcones. 
NVA-01 
(λmax = 371) 
NVA-02 
(λmax = 358) 
NVA-03 
(λmax = 359) 
NVA-04 
(λmax = 382) 
NVA-05 
(λmax = 383) 
pH OD pH OD pH OD pH OD pH OD 
2.89 1.4803 2.87 1.8127 2.52 1.6027 2.4 1.4827 2.53 1.6043
2.98 1.4801 3.19 1.8103 2.84 1.6003 2.72 1.4803 3.07 1.6007
3.43 1.4795 3.45 1.807 3.1 1.597 2.98 1.477 3.73 1.6001
3.89 1.4783 3.9 1.8033 3.55 1.5933 3.43 1.4733 4.18 1.5997
4.25 1.4769 4.34 1.797 3.99 1.587 3.87 1.467 4.37 1.5976
4.77 1.4763 4.74 1.7893 4.39 1.5793 4.27 1.4593 4.54 1.5963
5.61 1.4759 5.05 1.7851 4.7 1.5751 4.58 1.4551 5.01 1.5952
5.82 1.4733 5.48 1.7793 5.13 1.5693 5.01 1.4493 5.35 1.5925
6.02 1.4677 6.1 1.763 5.75 1.553 5.63 1.433 5.65 1.583 
6.15 1.4627 6.78 1.7527 6.43 1.5427 6.31 1.4227 5.93 1.5812
7.38 1.4563 7.6 1.7317 7.25 1.5217 7.13 1.4017 6.74 1.5766
8.02 1.423 8.48 1.6828 8.13 1.4728 8.01 1.3528 7.61 1.523 
8.65 1.3859 9.34 1.6128 8.99 1.4028 8.87 1.2828 8.21 1.4729
9.65 1.2959 9.98 1.5267 9.63 1.3167 9.51 1.1967 8.85 1.4319
10.41 1.2263 10.5 1.5003 10.15 1.2903 10.03 1.1703 9.93 1.3309
11.18 1.1661 10.88 1.4731 10.53 1.2631 10.41 1.1431 10.45 1.2832
11.84 1.1527 11.54 1.4327 11.19 1.2227 11.07 1.1027 11.67 1.2507
12.38 1.1463 12.38 1.4225 12.03 1.2125 11.91 1.0925 12.07 1.2493
12.41 1.1334 12.41 1.4195 12.52 1.2095 12.4 1.0895 12.55 1.2476
12.53 1.1325 12.47 1.4195 13.05 1.2095 12.93 1.0895 12.81 1.2467
12.65 1.1323 12.58 1.4194 13.06 1.2094 12.94 1.0894 13.07 1.2466
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Continue…. 
NVA-06 
(λmax = 365) 
NVA-07 
(λmax = 360) 
NVA-08 
(λmax = 359) 
NVA-09 
(λmax = 365) 
pH OD pH OD pH OD pH OD 
3.10 1.5903 2.68 1.8827 2.39 1.4943 2.6 1.5643 
3.29 1.5901 3.22 1.8803 2.93 1.4907 3.14 1.5607 
3.74 1.5895 3.88 1.877 3.59 1.4901 3.8 1.5601 
4.20 1.5883 4.33 1.8733 4.04 1.4897 4.25 1.5597 
4.56 1.5869 4.52 1.867 4.23 1.4876 4.44 1.5576 
5.08 1.5863 4.89 1.8593 4.41 1.4863 4.61 1.5563 
5.92 1.5859 5.16 1.8551 4.87 1.4852 5.08 1.5552 
6.13 1.5833 5.51 1.8493 5.12 1.4825 5.42 1.5525 
6.33 1.5777 5.82 1.833 5.51 1.473 5.72 1.543 
6.76 1.5727 6.08 1.8227 5.79 1.4712 6.11 1.5412 
7.69 1.5663 6.89 1.8017 6.60 1.4666 6.81 1.5366 
8.33 1.533 7.76 1.7528 7.47 1.413 7.68 1.483 
8.96 1.4959 8.36 1.6828 8.07 1.3629 8.28 1.4329 
9.96 1.4059 9.01 1.5967 8.71 1.3219 8.92 1.3919 
10.72 1.3363 9.87 1.5703 9.79 1.2209 10.11 1.2909 
11.49 1.2761 10.6 1.5431 10.31 1.1732 10.52 1.2432 
12.15 1.2627 11.82 1.5027 11.53 1.1407 11.74 1.2107 
12.69 1.2563 12.22 1.4925 11.93 1.1393 12.14 1.2093 
12.72 1.2434 12.47 1.4895 12.41 1.1376 12.62 1.2076 
12.84 1.2425 12.59 1.4895 12.67 1.1367 12.88 1.2067 
12.96 1.2423 12.77 1.4894 12.93 1.1366 13.14 1.2066 
13.03 1.2422       
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Table 3.6.2. pKa value from graph and Average pKa of chalcones 
Compound 
Code 
pKa value from 
graph (H1/2) Average pKa value
Correlation 
coefficient 
NVA-01 9.47 9.45 0.9775 
NVA -02 9.53 9.59 0.9907 
NVA -03 9.73 9.12 0.9928 
NVA -04 9.10 9.22 0.9923 
NVA -05 8.96 8.87 0.9930 
NVA -06 9.85 9.69 0.9914 
NVA -07 
5.51 
8.40 
5.57 
8.56 
0.9981 
0.9942 
NVA -08 8.84 8.76 0.9772 
NVA -09 9.01 8.96 0.9244 
 
Table 3.6.3 Arrange chalcones in order of increasing acidity or 
decreasing basicity strength by half protonation values as 
follows: 
Compound 
Code 
H1/2 Groups Acidity or basicity 
NVA -06 9.85 4-Br 
D
ec
re
as
in
g 
ba
si
ci
ty
 o
r i
nc
re
as
in
g 
ac
id
ity
 
 
in
cr
ea
si
ng
 b
as
ic
ity
 o
r D
ec
re
as
in
g 
ac
id
ity
 
 
NVA -03 9.13 -H 
NVA -02 9.53 4-NO2 
NVA-01 9.47 4-Cl 
NVA -04 9.10 4-CH3 
NVA -09 9.01 3-Cl 
NVA -05 8.96 4-OCH3 
NVA -08 8.84 2,4-OCH3 
NVA -07 
5.51 
8.40 
4-OH 
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Figure 3.6.1: The variation of OD with pH for NVA-01. 
 
 
Figure 3.6.2 : The plot of log I versus pH for NVA-01. 
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    INTRODUCTION  
Studies on thermal properties of substances are of great importance 
from both scientific and practical of view. Scientific and technological 
achievements together with demands based on industrial requirement have 
permitted the development of various types of materials that can with stand at 
much higher temperatures and more corrosive environments. 
Among the several instruments and technique, thermal analysis has 
grown rapidly in recent years. This increasing importance is due to the 
advancement of thermal analysis technology, relative cheapness of the 
equipment and time required to achieve the desired results. These techniques 
are able to characterize a wide range of materials and material properties. In 
these techniques, the change in properties of material are followed as a 
function of temperature when it is heated at constant predetermined rate 
under specified ambient atmospheric conditions. 
Some of the most commonly used techniques are Differential Scanning 
Calorimetry (DSC), Differential Thermal Analysis (DTA), Thermo Gravimetric 
Analysis (TGA), Evolved Gas Detection (EGD), Evolved Gas Analysis (EGA) 
etc. 
In the present study, thermal analysis is done by DSC and TGA 
techniques. Thermogravimetric analysis (TGA) is a thermal analysis technique 
which measures the weight change in a material as a function of temperature 
and time, in a controlled environment. This can be very useful to investigate 
the thermal stability of a material. 
Differential scanning calorimetry (DSC) is a simple and rapid method of 
estimating the purity of materials, which is used to provide quantitative and 
qualitative information about physical and chemical changes involving 
endothermic or exothermic processes or heat capacity changes.1,2 The 
method is based on the van’t Hoff law of melting point depression. 
Literature survey shows that thermal analysis of various types of 
compounds such as drugs3,4, dyes5-7 , fertilizers8,9, polymers10-13, pharma 
materials14-15, organic16-17 ,inorganic18-19 , vitamine20 , metal21 and compounds 
have been reported. Recently, a number of investigators22-27have studied the 
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thermal properties of various materials. However, the little works have done 
on the thermal properties of chalcones derivatives28-30.  
In the present study, thermal properties of some new synthesized 
chalcones have been studied by DSC and TGA techniques. 
Using thermograms, various kinetic parameters have also been 
evaluated. 
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THEORY: 
From TGA curves, various kinetic parameters can be evaluated by 
several methods. In all these methods, it is assumed that thermal and 
diffusion barriers are negligible because small quantity of material is used. 
The shape of any TGA curve depends on the nature of apparatus and the way 
in which it is used. Further, Arrhenius equation is valid in all these methods. 
 The kinetic treatments are generally based on the relationship of the 
type: 
          dC/dt = K f (C)     ... (3.7.1) 
where C is the degree of conversion, t is time and K is rate constant. f(C) is a 
temperature independent function of C. 
The constant K is assumed to have the Arrhenius form: 
             K = A e -E/RT    ... (3.7.2) 
C can also be defined as: 
             C = 1-(W/W0)                  ... (3.7.3) 
where W0 and W are the initial weight at t=0 and weight at any time t of the 
material. 
Equation (3.7.3) can be written as: 
             (W/W0) = (1-C)    ... (3.7.4) 
W/ W0 is known as residual weight fraction. 
Thus, the rate of conversion is, 
     dC/dt = - (1/W0) (dW/dt)    ... (3.7.5) 
For homogeneous kinetics, the conversion is assumed to be of the 
form: 
            f (C) = (1-C)n     ... (3.7.6) 
where n is the order of the reaction. 
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Substituting the values from equation (3.7.2) and (3.7.6) in equation 
(3.7.1) gives: 
                  dC/ dt = A e -E/RT (1-C)n 
              or       dC/dt = (A/β) e -E/RT (1-C)n    ... (3.7.7) 
where A is the frequency factor, β is the rate of heating and E is the energy of 
activation. 
Various methods for single and multiple heating rates have been 
reported. The methods of single heating rate are as follows: 
1.   Freeman-Carroll 31 and Anderson-Freeman Method 32: 
At a single heating rate, Freeman and Carroll gave the following 
relation to analysis TGA data : 
     ln (dC/dt)/ln (1-C) = n-E/R [(1/T/(Δln(1-C)]       ... (3.7.8) 
A plot of left hand side against (1/T)/(Δln(1-C)) gives a straight line with 
a slope equal to -E/R and the intercept is equal to n.  
Anderson and Freeman then derived the following equation by using 
equation (3.7.8): 
        (∆ln[dC/dt]) = n (∆ln(1-C)) - E/R ∆(1/T)      ... (3.7.9) 
The plot of (∆ln[dC/dt]) against (∆ln(1-C)) for equal intervals of ∆ (1/T) 
gives a straight line with slope equal to n and intercept -E/R∆ (1/T). 
2. Sharp-Wentworth method 33: 
To analyse the TGA data for first order kinetics (n=1), Sharp and 
Wentworth gave the relation: 
 log [(dC/dt)/(1-C)] = log (A/β) – (E /2.303R).(1/T)  ... (3.7.10) 
The plot of log [(dC/dt)/(1-C)] against 1/T would be a straight line with 
slope equal to - (E/2.303R) and intercept equal to log (A/ β). 
3.  Chatterjee Method 34: 
Based on the weight units, the following relation was developed by 
Chatterjee: 
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 n = [log(dW/dt)1-log(dW/dt)2] / (log W1-log W2)           ... (3.7.11) 
where W1 and W2 are the sample weights.  
4.  Horowitz and Metzger method 35  : 
In this method, the value of energy of activation E can be determined 
from a single TG curve by the relation: 
                ln [ln(1-C)-1] = (E/RTs
2
)θ                            ... (3.7.12) 
where θ = T-Ts. Ts is the temperature at which the rate of decomposition is 
maximum. The frequency factor A and entropy change ∆S can be determined 
by the following equations: 
       ln E - ln (RTs
2
) = ln A - lnβ  - E/RTs          ... (3.7.13) 
            A = (kbT / h) e ∆S/R                                ... (3.7.14) 
where kb is Boltzmann constant and h is Planck’s constant. 
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    EXPERIMENTAL 
          Thermo gravimetric analysis (TGA) and Differential Scanning 
Calorimetry (DSC) measurements were made on the instrument “Pyris-1, 
Perkin Elmer Thermal Analysis” at the heating rate of 10 0C/min in nitrogen 
atmosphere for all the chalcones derivatives. 
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    RESULTS AND DISCUSSION 
The TGA and DSC thermograms of NVA-1 and NVA-2 are given in 
Figure 3.7.1 and 3.7.2. Various thermal properties such as initial 
decomposition temperature, the decomposition temperature range, the 
maximum degradation, the percentage weight loss, transitions along with 
DSC temperature of all the synthesized chalcones derivatives are reported in 
Table 3.7.1. 
 For all the compounds, degradation is single step process. Further, the 
the decomposition temperature for all the studied compounds are not very 
high. Looking to the value of maximum degradation temperature reported in 
Table 3.7.1, it is evident that NVA-8 is most stable whereas NVA-2 is least 
stable. This suggests that the presence of methoxy group increases stability 
whereas p-nitro group decreases the stability to a greater extent. The thermal 
decomposition may depend on different structural as well as electronic 
intermolecular interactions. Further, maximum weight loss is observed for 
NVA-5, followed by NVA-3, NVA-7 and NVA-9. 
 Further, from the thermograms, various kinetic parameters, such as 
order of the degradation (n), energy of activation (E), frequency factor (A) and 
entropy change (∆S) have also been calculated and are reported in Table 
3.7.2.  
It is evident from Table 3.7.2 that order of reaction varies from 1.06 to 
6.17 for the studied compounds.  
The energy of activation (E) is highest for NVA-4 and minimum for 
NVA-5. The frequency factor (A) also varies in the same order i.e., maximum 
for NVA-4 and minimum for NVA-5. 
Further, change in entropy (∆S
0
) for all these degradations were also 
calculated by equation (3.7.14) and are reported in Table 3.7.2. It is observed 
that entropy (∆S
0
) values are positive for NVA-3, NVA-4, NVA-7, NVA-8 and 
NVA-9 whereas for other compounds, ∆S0 values are negative. 
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The positive ∆S0 indicates that the transition state is less ordered than 
the original compound whereas negative ∆S
0
 corresponds to an increase in 
the order of transition state than the reactants. 
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Figure 3.7.1: The TGA thermograms of NVA-1 and NVA-2. 
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      Table 3.7.1: TGA/DSC data for synthesized NVA series. 
Comp. 
Code 
Amt. 
mg. 
Initial 
Decomp. 
Temp. 
oC 
Decomp. 
range 
oC 
% Wt. 
loss 
Residual Wt. 
Loss 
mg. 
Transition 
M. P. by 
DSC 0C 
 
M. P. by 
Open capillary 
0C 
 
NVA-1 6.105 150 150-450 67.41 4.1150 Endo 151 153 
NVA-2 6.642 80 80-450 55.51 3.8138 Endo 151.92 153 
NVA-3 7.131 150 150-496 93.14 6.7245 Endo 130.86 132 
NVA-4 8.398 125 125-497 75.62 6.4437 Endo 124.68 124 
NVA-5 6.375 130 130-500 95.96 6.1512 Endo 151.21 151 
NVA-6 6.115 160 160-496 65.27 4.1221 Endo 139.01 134 
NVA-7 7.111 160 160-496 93.14 7.7383 Endo 130.20 133 
NVA-8 6.742 175 175-498 87.41 5.8931 Endo 129.66 129 
NVA-9 7.211 160 160-496 93.94 6.8186 Endo 168.86 170 
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Table 3.7.2: The kinetic parameters of chalcones derivatives. 
 
Comp. code n 
E 
kJ.mol-1 
A 
s-1 
∆S 
J.mol-1.K-1 
NVA-1 5.09 16.42 1.39E+00 -93.7675 
NVA-2 6.17 16.43 1.43E+00 -93.5315 
NVA-3 1.66 150.49 1.32E+14 173.7023 
NVA-4 2.69 176.07 3.31E+16 219.5435 
NVA-5 2.72 1.74 5.11E-03 -140.477 
NVA-6 4.43 20.49 4.77E+00 -83.4241 
NVA-7 1.65 152.27 2.30E+14 178.3199 
NVA-8 1.06 138.51 1.72E+13 156.9048 
NVA-9 1.71 125.23 1.12E+13 154.0233 
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Further, the melting points of studied compounds were evaluated from 
DSC. Figure 3.7.2 shows DSC of NVA-1 and NVA-2 and melting points of all 
the compounds are reported in Table 3.7.1 along with those observed by 
open capillary method. Comparison of melting points, obtained by both 
methods is found to be in good agreement.  
Thus, the degradation in the studied compounds is single step process 
with different order of reaction. Further, thermal stability depends upon the 
type of substituent present. 
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Figure 3.7.2: The DSC graphs of NVA-1 and NVA-2. 
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INTRODUCTION 
Biological activity is an expression describing the beneficial or adverse 
effects of a drug on living matter. When the drug is a complex chemical 
mixture, this activity is exerted by the substance's active ingredient or 
pharmacophore but can be modified by the other constituents. The main kind 
of biological activity is a substance's toxicity.  
Biological activity spectrum of a compound represents the 
pharmacological effects, physiological and biochemical mechanisms of action, 
specific toxicity which can be revealed in compound’s interaction with 
biological systems. Further, it describes the intrinsic properties of the 
compound, which depends on its structure. 
A literature survey shows that Chalcones have been reported to 
demonstrate a wide rage of pharmacological activities.1This class of 
compounds are known to possess a wide spectrum of biological activities 
such as antiinflammatory2, antitumor3, antimalarial,4, antifungal5, antiulcer6, 
analgesic7, anti-HIV8 properties. 
 Upadhyay et al. have studied antimicrobial activity of 
chalcones.9 The antimicrobial activity of some novel benzimidazolyl chalcones 
have also been reported by Baviskar et al. 10 Recently, Dawane et al. have 
also been reported antimicrobial activities chalcones derivatives.11 
Lee et al. have reported tris(methoxy)chalcone to be an anti-
inflammatory compound that reduces nitric oxide (NO) production by inhibiting 
inducible nitric oxide (NO) synthase expression. The findings suggest that 
some chalcones may be promising anti-inflammatory agents.12 The anti-
inflammatory activity of substituted chalcones derivatives have also been 
reported by Zhang et al. 13   
Chalcones are also key precursors in the synthesis of many biologically 
important heterocycles such as benzothiazepine14, pyrazolines15, 1,4-
diketones16 and flavones.17 Hence, the synthesis of chalcones has generated 
vast interest among organic as well as medicinal chemists.  
In the present section, the antibacterial activity of some new Chalcones 
has been studied against some Gram positive and Gram negative bacteria in 
DMSO. 
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EXPERIMENTAL 
 The solvent DMSO was also purified before use by standard method.18 
All the synthesized compounds were re crystallized prior to use. For all the 
compounds, agar well diffusion method was used. 
 
Test Microorganisms: 
The synthesized compounds were tested for its antibacterial activity 
against Gram positive bacteria viz. Streptococcus pyogenes (NCIE 1925), 
Bacillus subtilis (ATCC 2274) and Gram negative bacteria viz. proteus 
mirabilis (NCIM 2241), salmonella typhimurium (ATCC 23564). 
Microorganisms were obtained from National Chemical Laboratory 
(NCL), Pune, India and were maintained at 4°C on nutrient agar slants. 
Preparation of test compounds: 
The solutions were prepared at a concentration of 1 mg/μl for all the 
compounds. 
Preparation of the plates and microbiological assay: 
The antibacterial evaluation was done by agar well diffusion method2,3 
using Mueller Hinton Agar No.2 as the nutrient medium. The agar well 
diffusion method was preferred to be used in this study because it was found 
to be better than the disc diffusion method as suggested by Parekh et al.3 The 
bacterial strains were activated by inoculating a loop full of test strain in 25 ml 
of N-broth and the same was incubated for 24 h in an incubator at 37o C. 0.2 
ml of the activated strain was inoculated in Mueller Hinton Agar. Mueller 
Hinton Agar kept at 45oC was then poured in the Petri dishes and allowed to 
solidify. After solidification of the media, 0.85 cm ditch was made in the plates 
using a sterile cork borer and these were completely filled with the test 
solution. The plates were incubated for 24 h at 37oC.  The mean value 
obtained for the three wells was used to calculate the zone of growth inhibition 
of each sample. The controls were maintained for each bacterial strain and 
each solvent. The inhibition zone formed by these compounds against the 
particular test bacterial strain determined the antibacterial activities of these 
synthesized compounds.  
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RESULTS AND DISCUSSION 
Figure 4.1 shows inhibition against Gram positive bacteria in DMSO. It 
is observed that against S. pyogenes, NVA-9 showed maximum inhibition 
whereas NVA-2, NVA-3 showed minimum inhibition. NVA-1, NVA-4 and NVA-
5 showed no inhibition at all.  
 For B. subtilis, again NVA-9 exhibited maximum and NVA-1, NVA-3 
and NVA-4 exhibited minimum inhibition.  
Thus, in DMSO NVA-9 is the most effective compound for the studied 
bacteria. 
Figure 4.2 shows inhibition against Gram negative bacteria in DMSO. 
Against P. mirabilis, NVA-5 showed maximum inhibition whereas NVA-4 had 
no effect on the bacteria. For S. typhimurium, NVA-8 showed maximum 
inhibition whereas NVA-2 shows minimum inhibition. There is no effect of 
NVA-6, NVA-4. 
The inhibition depends on the solvent, compound structure and 
bacterial strain. NVA-9 contains m-chlorobenzene which is found to be 
effective for both Gram positive bacteria. Whereas NVA-1, NVA-4 and NVA-5, 
containing p-chloro benzene, p-methyl benzene and p-methoxy benzene 
respectively could not affect these bacteria.  
However, for Gram negative bacteria, p-methoxy benzene (as in NVA-
5) is most effective against P. mirabilis whereas for S. typhimurium, o,p-
dimethoxy benzene (as in NVA-8) is found to affect most. The presence of p-
methyl benzene (in NVA-4) had no effect on both Gram negative bacteria. For 
S. typhimurium, p-bromo benzene (in NVA-6) also had no affect. Thus, the 
presence of p-methoxy benzene increases the inhibition in the studied 
bacteria.  
Thus, it can be concluded that for the studied chalcones derivatives,  
the chloro group showed best antibacterial activity provided, it was at meta 
position while the same chloro group at para position decreased the activity 
for Gram positive bacteria. However, for Gram negative bacteria, methoxy 
group showed best activity at para position. Whereas at meta and para 
positions, the same methoxy group exhibited less activity. Thus, substitution 
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affects the inhibition to a larger extent and studied compounds showed more 
inhibition against Gram positive bacteria. 
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Figure 4.1: Antibacterial activity of chalcones against Gram positive 
bacteria in DMSO. 
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Figure 4.2: Antibacterial activity of chalcones against Gram negative 
bacteria in DMSO. 
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A COMPREHENSIVE SUMMARY OF THE WORK 
The present work is divided into following chapters: 
 
CHAPTER - 1: This chapter describes the importance of heterocyclic 
compounds with aims and objective of the present work.         
 
CHAPTER - 2: The synthesis of Chalcones, Acetyl pyrazolines, 
Dihydropyrimidinethiones, Dihydropyrimidinones, and Aminopyrimidines are 
described in this chapter. . Further, the characterizations of all the synthesized 
compounds are done by IR, NMR and mass spectral data. The chapter is 
divided into five sections. 
 
Section-I: In this section, synthesis of Chalcones are given along with their 
physical constant data.  The spectra and the characteristic peak positions of 
IR and NMR spectra are reported. Further, mass spectra and possible 
fragmentation scheme are given in this section. 
 
Section-II: This section deals with the synthesis of Acetyl pyrazolines. The 
physical constant data is also reported along with spectra and the 
characteristic peak positions of IR and NMR spectra. The mass spectra and 
possible fragmentation scheme are given. 
 
Section-III: This section describes the synthesis of dihydropyrimidinthions. 
The physical constant data, IR and NMR spectra and their spectral data and 
mass spectra and possible fragmentation scheme are given. 
 
Section-IV: In this section, synthesis of dihydropyrimidinones, their physical 
constant data, IR and NMR spectra and their spectral data and mass spectra 
and possible fragmentation scheme are given. 
 
Section-V: The synthesis of 2-amino-dihydropyrimidines, their physical 
constant data, IR and NMR spectra and their spectral data and mass spectra 
and possible fragmentation scheme are given in this section. 
 
Studies of some bio active heterocyclic……. 
 
                                                                                  A Comprehensive Summary of the Work                          
 211 
 
CHAPTER - 3: The physicochemical properties of synthesized chalcones was 
also studied. The different properties are given in different sections. For the 
study of all physicochemical properties, DMF and Chloroform are used. 
 
Section-I: This section describes the acoustical properties of chalcones in 
DMF and chloroform solutions at 303.15 K. The density, ultrasonic velocity 
and viscosity of a series of solutions of various concentrations were measured 
in both the solvents for all the chalcones. From these experimental data, 
various acoustical parameters were evaluated which helped to understand the 
different types of interactions occurring in the solutions. It is observed that for 
both the series, in the studied solvents, solute-solvent interactions dominate.  
 
Section-II:  In this section, the densities and refractive index of all the 
chalcones were measured in DMF and Chloroform solutions at 303.15 K. The 
experimental density values are found to be different than those calculated 
theoretically for all the studied systems, which may be due to solvation of ions 
in solutions. In solutions of different solvents, density is found to be different 
due to different interactions. Further, molar refraction and refractive index of 
chalcones were determined which are found to be different in each solvent.  
 
Section-III:   This section deals with the conductance of studied compounds  
in solutions of DMF and Chloroform at 303.15 K. It is observed that for all the 
studied compounds, conductivities are less in Chloroform than in DMF. 
Further, all the studied compounds exhibited weak electrolytic nature in both 
the solvents. 
  
Section-IV: This section describes the solubility and thermodynamic 
parameters of all the studied compounds in dichloromethane (MDC) and 
Chloroform at different temperatures (293.15 -313.15 K). It is observed that 
the solubility of all the compounds increases linearly with temperature in both 
the solvents. Comparison of solubility of these compounds in MDC and 
Chloroform shows that overall solubility is greater in Chloroform than in MDC. 
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The thermodynamic parameters such as Gibb’s energy (∆Gs), enthalpy (∆Hs) 
and entropy (ΔSs) for the dissolution process in the two solvents were also 
evaluated for all the compounds. It is observed that enthalpy and Gibb’s 
energy are positive for all the compounds whereas entropy values are both 
negative and positive. The positive ∆Hs indicates endothermic dissolution of 
compounds whereas positive ΔG suggests that the dissolution process is not 
spontaneous. Further, the negative values of entropy indicate less random 
ness in solutions.  
 
Section-V:. This section describes partition coefficient of chalcones, which 
has been studied in n-Octanol-water system by UV spectroscopy at different 
pH. It is concluded that out of all studied compounds, NVA-07 exhibits 
maximum hydrophobic nature. 
 
Section-VI: The dissociation constants of chalcones in DMF: water (90:10) 
system is studied by UV spectroscopy in this chapter. It is observed that 
acidity is maximum in NVA-07 having hydroxy group as expected whereas for 
NVA-06 having halogen group, acidity is minimum. Thus, dissociation is 
maximum for NVA-7 and minimum for NVA-6. 
 
Section-VII: The thermal properties of synthesized chalcones are described 
in this section.  DSC and TGA thermo grams were scanned at the heating rate 
of 100 C per minute. It is observed that thermal stability depends on the 
presence of substituents in the compound. Out of all the studied compounds, 
NVA-8 is most stable whereas NVA-2 is least stable. This suggests that the 
presence of methoxy group increases stability whereas p-nitro group 
decreases the stability to a greater extent. The thermal decomposition may 
depend on different structural as well as electronic intermolecular interactions. 
Further, maximum weight loss is observed for NVA-5, followed by NVA-3, 
NVA-7 and NVA-9. 
  Further, the melting points determined by DSC and by open capillary 
methods are found to be in good agreement.  
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Various kinetic parameters such as order of reaction, energy of 
activation, frequency factor and entropy change were also calculated. Thus, 
the degradation in the studied compounds is single step process with different 
order of reaction.  
 
CHAPTER - 4: The antibacterial activities of all the synthesized chalcones in 
DMSO are explained in this chapter. Both Gram positive and Gram negative 
bacterial were taken for the study. It is observed that different compounds 
affect differently to different bacterial strains depending upon their substitution 
group. 3-chloro benzene is most effective for Gram positive bacteria. Against 
Gram negative bacteria, 4-methoxy benzene and 2,4-dimethoxy benzene are 
found to be most effective. 
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